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ABSTRACT 
Nicole Marie Juliette Schwerbrock: Dietary Polyunsaturated Fatty Acids Modulate 
Immunity to Influenza Virus Infection  
 (Under the direction of Melinda A. Beck, PhD.) 
 
Dietary fish oils, rich in n-3 polyunsaturated fatty acids (PUFA), including 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known to have 
anti-inflammatory properties. While the immunosuppressive effects of n-3 PUFA may 
be beneficial for some chronic inflammatory disorders, these same anti-inflammatory 
properties may be detrimental for a response to an infection when a functional 
immune system is needed to eradicate an invading pathogen.  
 Despite the availability of vaccines and antiviral agents, influenza virus 
continues to be a major cause of morbidity and mortality worldwide. Given that n-3 
PUFA-rich fish oil supplementation by human populations is on the rise, and with the 
increasing threat of an influenza pandemic, we tested the impact of fish oil feeding 
on the immune response to influenza virus infection.  
Using in vivo and in vitro models, we found n-3 PUFA, supplied at 
physiologically relevant levels, suppressed immune responses following influenza 
infection. Although the anti-inflammatory properties of fish oil resulted in decreased 
lung inflammation in influenza infected mice, it also led to increased mortality and 
increased viral titers in surviving mice post infection. Impairment of host resistance 
was likely due to reduced inflammatory cell trafficking into the lungs in conjunction 
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with lower cytokine production during infection. Influenza virus infection also resulted 
in a significant increase in EPA content in the infected lung, while infection had little 
effect on DHA in fish oil fed mice. Although changes in fatty acid membrane profiles 
can result in functional changes, dendritic cells and T cells from infected fish oil fed 
mice were able to respond to viral antigen equivalent to control fed mice.  
In response to viral infection, airway epithelial cells induce pro-inflammatory 
and antiviral mediators. We found that specific DHA to EPA ratios suppressed these 
mediators of infected human primary bronchial epithelial cells. Together, data from 
our studies indicate that n-3 PUFA treatment can have a profound effect in the host 
response to influenza virus infection.  
Given that fish oil supplementation is used by both adults and children, there 
is a significant public health benefit in further investigating how PUFAs alter immune 
function.  
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CHAPTER I 
BACKGROUND AND SIGNIFICANCE 
Polyunsaturated fatty acids (PUFAs) may have important roles in the 
prevention of chronic diseases because they are capable of reducing excessive 
inflammation (1). Suppression of the immune system, however, may be deleterious 
during influenza virus infection and others, when inflammation is essential for  
eliminating the invading pathogen (2). This introductory chapter reviews the structure 
and the uses of PUFAs and sets the stage for the presentation of new research on 
the relationship between the immune system and PUFAs, following infection with 
influenza virus in vivo and in vivo. 
1.1 Polyunsaturated fatty acids: Their significance in public health 
 
Over the years, researchers have become increasingly aware of the role diet 
plays in immune function. Studies have shown that dietary PUFAs derived from fish 
oil have beneficial effects on inflammatory and autoimmune disorders, suggesting 
that fish oil has both anti-inflammatory and immunomodulatory effects (3-5). 
Although the immunosuppressive properties of PUFAs may be beneficial during an 
inflammatory illness, their anti-inflammatory properties may be detrimental when the 
body is combating an infection, such as influenza virus (2, 6). 
 
 
1.1.1 Dietary PUFA: Source and chemistry 
 
PUFAs are unique fatty acids with 18 or more carbons, containing two or 
more double bonds in cis configuration. PUFAs are grouped into two series based 
on the origin of the position of the terminal double bond, located either on carbon 3 
or carbon 6 from the methyl end (omega carbon) of the fatty acid chain (7, 8). 
Depending on these positions, PUFAs are classified as omega-3 (n-3) or omega-6 
(n-6) fatty acids (8).  
One of the subgroups of n-3 fatty acids, alpha-linolenic acid (ALA, 18:3n-3), is 
derived from plant oils. The other subgroup of n-3 PUFAs is derived from cold water 
fish; the major marine n-3 PUFAs are eicosapentaenoic acid (EPA; 20:5n-3) and 
docosahexaenoic acid (DHA; 22:6n-3). Two major kinds of n-6 PUFAs are linoleic 
acid (LA; 18:2n-6) and arachidonic acid (AA;20:4n-6), which are derived mostly from 
vegetable oils and red meats, respectively (7). Figure 1.2.1 shows the structures of 
the most prominent omega-3 fatty acids, eicosapentaenoic acid (EPA; 20:5n-3) and 
docosahexaenoic acid (DHA; 22:6n-3), and the most prominent omega-6 fatty acid, 
arachidonic acid (AA; 20:4n-6). 
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Figure 1.2.1 Structures of polyunsaturated fatty acids (PUFAs).  
The nomenclature of PUFAs indicates the number of carbon atoms in the chain, the number of 
double bonds and the position of the first double bond from the methyl terminus of the chain, 
indicated by the letter n (9). 
 
 
Methyl end of the 
fatty acid chain  
N-3 PUFAs are considered essential for the human diet. Humans and other 
mammals cannot create double bonds before the 9th carbon because they lack the 
enzymes ∆12-desaturase and ∆15-desaturase. ∆12-desaturase creates a double 
bond at the 6th carbon, whereas ∆15-desaturase creates a double bond at the 3rd 
carbon. Both of the desaturase enzymes, however, exist in plants and fish (8), the 
major dietary source of n-3 PUFAs. 
Following the absorption of PUFAs from foods, they are distributed by the 
blood to all cells in the body. They typically incorporate into the sn-2 position of 
phospholipids in the lipid bilayer of cellular membranes (Figure 1.2.2a) (4, 10). 
Because of the multiple double bonds within the fatty acid chain, PUFAs can adapt 
different confirmations within the cell membranes (Figure 1.2.2b) 
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Figure 1.2.2 A schematic representation of a phospholipid molecule.  
1.2.2 b. EPA and DHA crustal structure. Modified from Eckhardt (11). Green arrows point to 
predominant incorporation of n-3 PUFAs. 
 
 
N-3 PUFAs are generally considered positive for human health, whereas n-6 
PUFAs can be converted to pro-inflammatory agents and are therefore thought to be 
less beneficial when consumed in excess (3, 12). This notion stems from the fact 
that n-6 AA is the main precursor for prostaglandins, which have pro-inflammatory 
properties (discussed below in section 1.4.1) (8, 13). Maintaining a healthy n-6/n-3 
balance is therefore important (discussed below in section 1.2.1)  
Although most studies demonstrate a beneficial effect of n-3 PUFAs on 
inflammatory and autoimmune disorders, some concern remains that the anti-
inflammatory properties of n-3 PUFAs may be detrimental during acute infections (2, 
14). However, there has not been sufficient investigation to determine whether the 
intake of n-3 PUFAs affects the immune response to infectious disease. 
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1.1.2 Evolutionary aspect of diet: How has the American diet changed? 
The human diet has undergone striking changes in evolution and agricultural 
development. The n-3 PUFA content of today’s diet is noticeably lower than during 
earlier periods in human history because of changes in dietary habits resulting from 
the development of agricultural techniques and the consumption of processed foods 
(15, 16). Foods of the hunter and scavenger period (2.5 million years ago) were 
considered to be richer in n-3 PUFA consumption and a healthier balance between 
n-6 and n-3 PUFAs existed (i.e., n-6/n-3 ratio ≈ 1:1). Deviation from this balance 
began about 10,000 years ago with the adoption of agriculture and animal 
husbandry (16).   
Industrial revolution over the last 300 years or so increased meat 
consumption and decreased consumption of plant foods and fish in western society. 
This increase has led to an imbalance in intakes of the two food types of PUFAs, 
resulting in an increased n-6/n-3 fatty acid ratio, as high as 15 –20:1 (5, 16, 17). In 
the last century, total fat intake increased and both absolute and relative changes of 
n-6/n-3 ratio in the diet of Western societies has occurred (Figure 1.2.3) (16).  
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Figure 1.2.3 Scheme of total fat and fatty acid intakes throughout evolution.  
Data were extrapolated from cross-sectional analyses of contemporary hunter-gatherer populations 
and from longitudinal observations and their putative change during the preceding 100 years. 
Modified from Simopoulos (18). 
 
 
A high n-6/n-3 ratio has been suggested to have adverse effects on human 
health, which has in turn led to a recommended increase in the intake of n-3 PUFAs 
and a decrease the consumption of n-6 fatty acids (16, 17). To achieve these goals, 
the American Heart Association recommends 1g/day of n-3 PUFAs for the 
prevention of cardiovascular disease (19). In addition, the Center for Nutrition Policy 
and Promotion, a division of the USDA, recommends eating specific types of fish, 
such as salmon, trout, and herring, for their high content in EPA and DHA (20). The 
“Dietary Guidelines for Americans 2005” published jointly by DHHS and USDA, 
suggests that total intake of PUFAs should remain at 7% of energy intake and not 
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exceed 10% of energy intake (21, 22), but with no recommendation of a healthy ratio 
of the two types of PUFAs. 
Although U.S. food disappearance data from 1985 to 1994 shows a 
decreased ratio of n-6/n-3 PUFA from 13:1 to 11:1, an additional 4-fold increase in 
fish consumption would still be necessary to attain the AHA recommended Adequate 
Intake (AI) of 0.65 g per day in EPA and DHA, resulting in a suggested ratio of 4:1 or 
lower (19, 23). 
Currently no Recommended Dietary Allowances (RDA) have been 
established for n-3 or n-6 PUFAs. The health benefits of n-3 PUFAs are considered 
to outweigh the health risks (24), but quantitative requirements have not been 
adequately investigated. The promotion of an increase in n-3 PUFA intake has 
resulted in an industry initiative to promote supplementation with fish oil capsules 
and fortification of n-3 PUFAs in processed foods (25). A survey conducted among 
health care professionals in 2006 found that fish oil capsules were consumed by 
24% of those surveyed (26). A follow-up study, conducted by the same group, 
reported an increase in fish oil supplementation from 24% to 30% in 2007 (27).  
1.2 Specific objectives 
The goal of this dissertation is to investigate if fish oil feeding can influence 
host resistance to influenza infection. We characterized phenotypes, numbers and 
functionality of cells infiltrating the infected lung using an in vivo model that closely 
resembles human conditions in dietary fish oil intakes and pathogen. Additionally, 
we used in vitro models to illustrate effects of PUFAs treatment on influenza virus 
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growth and related our cell culture experiments to explain mechanisms occurring in 
fish oil fed mice.  
1.3 Influenza virus infection and its widespread influence 
Influenza A virus is a RNA virus that can cause severe illness in humans and 
animals. Influenza A virus can infect cells throughout the respiratory tract and cause 
acute and diffuse inflammation of the bronchoaveolar tract (28, 29). Infection with 
influenza is characterized by a rapid infiltration of immune cells, such as neutrophils, 
monocytes, macrophages and natural killer cells, in the infected lungs. These cells 
are necessary for viral clearance but also contribute to lung pathology (30). 
Influenza virus continues to be a major worldwide cause of morbidity and 
mortality despite the availability of vaccines and antiviral agents. Infection with 
influenza virus was reported to be responsible for greater than 200,000 
hospitalizations and more than 30,000 deaths in the US annually, and these 
numbers are increasing among groups at high risk, such as the very young, elderly, 
and immuno-compromised individuals (31-33). During a periodic pandemic, 20-40% 
of the world’s population might be infected (34), and the increasing threat of an 
influenza pandemic underscores the importance of knowing the linkage between an 
n-3 PUFA-enriched diet and the body’s immune response to this virus.  
1.3.1 Effects of dietary PUFAs on infectious disease 
Epidemiological, clinical, and animal studies have demonstrated that PUFAs 
attenuate immune-mediated inflammatory diseases (1, 5). However, for example, 
epidemiologists have noted that populations that consume large quantities of oily 
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fish, such as Greenland Eskimos, suffered low death rates from ischemic heart 
disease, but higher incidence rates of tuberculosis (35). But, in addition, northern 
Canadian Indian and Inuit children suffered from recurrent and persisting upper 
respiratory tract and chest infections associated with weakened immunity (36). 
In animal models, fish oil diets have been shown to delay and weaken the 
immune response to infection, resulting in reduced clearance of some bacteria and 
viruses (2, 37). For example, diets supplemented with fish oils have been shown to 
lower host resistance to Mycobacterium tuberculosis (14), to reduce the survival of 
mice infected with Listeria monocytogenes (38, 39), and to decrease natural 
resistance of mice infected with Salmonella typhimurium (40). Similarly, fish oil 
feeding may diminish host defense against influenza virus due to delays in influenza 
virus clearance (37). These studies support the conclusion that the 
immunosuppressive effects of n-3 PUFAs are associated with a decline in cytokine 
production (41, 42), natural killer (NK) cell activity (43), antigen presentation (44, 45), 
lymphocyte function, and T-cell responses (46, 47). Each of these will be discussed 
in section 1.6. 
1.4 The synthesis of polyunsaturated fatty acids 
As stated earlier, mammals lack the enzymes ∆12-desaturase and ∆15-
desaturase, and therefore cannot convert oleic acid (18:1) into linoleic acid (18:2 n-
6) or into α-linolenic acid (18:3 n-3). Consequently, these fatty acids must be 
obtained through the diet. Dietary sources rich in linoleic acid (18:2 n-6) include 
corn, sunflower, safflower, and soybean oils, and dietary sources rich in α-linolenic 
acid (18:3 n-3) include rapeseed and flax seed oil. Once consumed, linoleic acid can 
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be converted via intermediates γ-linolenic acid (18:3n-6) and dihomo-γ-linolenic acid 
(20:3n-6) to arachidonic acid (AA; 20:4n-6) (Figure 1.2.4). Using the same pathway, 
dietary α-linolenic acid can be converted to eicosapentaenoic acid (EPA; 20:5n-3), 
docosapentaenoic acid (22:5n-3) and docosahexaenoic acid (DHA; 22:6n-3). This 
conversion however is very inefficient and only accounts for ~10% of the 
endogenous synthesis (7). n-6 and n-3 PUFAs compete for the same metabolic 
enzymes, thus causing the n-3 PUFA synthesis to occur at the expense of n-6 PUFA 
synthesis, and vice versa (13). As a result, the dietary intake of either n-6 or n-3 
PUFAs determines the amounts of the products synthesized.  
Figure 1.2.4 Fatty acid biosynthetic pathways.  
Adapted from (48).  
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1.4.1 PUFA content in cells membranes of the immune system 
Baseline fatty acid profiles are similar in rodent splenocytes and human 
peripheral blood mononuclear cells (PBMC) (49). The phospholipids of PBMC 
contain about 6-10% linoleic acid, 1-2% dihomo-γ-linolenic and 15-25% archidonic 
acid (50, 51). The proportions of n-3 PUFAs are low, with EPA and DHA 
compromising only 0.1-0.8% and 2-4%, respectively (52). Feeding studies in 
humans and rodents have shown a dose-dependent relationship with PUFA intake 
correlating to a higher proportion of PUFAs in immune cells (53). In general, the 
increase in content of n-3 PUFAs occurs at the expense of n-6 PUFAs and vice 
versa (54-56). In rodents that are maintained on chow diets, 18:3n-3 (α-ALA) and 
EPA are minor PUFAs in the phospholipid fraction. However, supplementing diets 
with fish oil significantly increases tissue levels of EPA and DHA; these changes 
occur at the expense of AA (4, 7). Time-course studies have shown that, depending 
on diet, the incorporation of EPA and DHA into immune cells reaches its peak within 
2-4 weeks of commencing increased intakes (49). Thus, the feeding of diets high in 
n-3 PUFAs is reflected in the membrane content of immune cells. 
1.5 Mechanisms by which PUFAs modulate the immune system  
Fatty acids fulfill a variety of roles within immune cells, including 1) fuels for 
generation of energy, 2) components of cell membrane phospholipids contributing to 
the physical and functional properties of those membranes, 3) covalent modifiers of 
protein structure influencing the cellular location and function of proteins, 4) 
regulators of gene expression either through effects on receptor activity, on 
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intracellular signaling processes, or on transcription factor activation, 5) precursors 
for synthesis of bioactive lipid mediators like prostaglandins (PGs), leukotrienes 
(LTs), lipoxins and resolvins (1). 
The next two sub-chapters will focus on PUFAs effect on eicosanoid 
metabolism and membrane structure. 
1.5.1 PUFAs effects on eicosanoid metabolism 
Eicosanoids are synthesized from 20-carbon PUFAs that are esterified with the 
hydroxyl group at the sn-2 position on the glycerol backbone of polar phospholipids 
(Figure 1.2) (7).  Normally, membranes of immune cells contain AA at the sn-2 
position, causing AA to be the predominant precursor for eicosanoid biosynthesis (1, 
7). AA is hydrolyzed from the sn-2 position by the enzyme phospholipase A2 (PLA2). 
Subsequently, non-esterified, free AA becomes a substrate for cyclooxygenase1 
(COX1), a constitutive enzyme, or COX 2, an inducible enzyme. Cyclooxygenase 
products of AA lead to the synthesis of prostaglandins (PG). Alternatively, AA can 
act as a substrate for one of the lipoxygenase (LOX) enzymes, forming 4-series 
leukotrienes (LT) (Figure 1.2.5).  
With an increased consumption of fish oil, a decrease in the amount of AA in 
immune cells and therefore less AA substrate becomes available for synthesis of 2 
series PG (Figure 4). Peterson et al. and Yaqoob et al. demonstrated a direct 
relationship between AA content of immune cell phospholipids and the ability of 
those cells to produce PGE2, such that PGE2 production is increased by AA feeding 
and decreased by EPA or DHA feeding (53, 57).   
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PGE2 generated from AA has both pro- and anti-inflammatory effects, thus 
making it a potent regulator of immune function. Pro-inflammatory effects include 
inducing fever, increasing the vascular permeability, increasing vasodilation and 
enhancing pain (52). Cell culture studies have demonstrated that PGE2 induces the 
production of the inflammatory cytokine IL-6 by macrophages (58).   
Alternatively, PGE2 synthesis can inhibit lymphocyte proliferation and NK cell 
activity by reducing the production of cytokines IL-2 and IFN-γ. In lipopolysaccharide 
(LPS) stimulated monocytes, the production of PGE2 inhibits the induction of 
cytokines TNF-α and IL-1β (59, 60), and PGE receptor knockout mice (EP2–/–  and 
EP4–/– ) have been shown to experience reduced T cell function (61).   
The synthesis of LTB4, on the other hand, has pro-inflammatory effects. LTB4 
synthesized from AA induces the production of pro-inflammatory cytokines TNF-α, 
IL-1, IL-6, IL-2 and IFN-γ from inflammatory cells, enhances lymphocyte proliferation 
and promotes NK cell activity (52).   
By adding fish oils to the diet or media to cell culture, EPA acts as a substrate 
for both COX and LOX, giving rise to derivatives which have a different structure 
from those produced from AA (i.e. 3-series PG and 5-series LT). When EPA is used 
instead of AA, series-3, rather than series-2 prostaglandins and leukotrienes are 
synthesized (Figure 1.2.5). With fish oil supplementation in humans, n-3 fatty acids 
derived from LTB5 block the biosynthesis of pro-inflammatory AA derived LTB4 and 
accelerate the production of LTB5 in inflammatory cells (13, 62). Because the series-
3 molecules derived from EPA have a slightly different structure, they are less potent 
inflammatory mediators than those formed from AA. Thus, the n-6/n-3 ratio in the 
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diet strongly affects eicosanoid production. The increased consumption of n-3 
PUFAs leads to reduced synthesis of pro-inflammatory eicosanoids from AA, and 
thus to a decrease in inflammation (7, 63, 64).  
Figure 1.2.5 Effects of PUFA on eicosanoid metabolism.  
Modified from Calder (64). 
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1.5.2 PUFAs effects on membrane structure. 
Within the lipid bilayer of cell membranes there are lipid domains with a 
distinct, structural composition that act as platforms for proteins involved in 
intracellular signaling pathways. Membrane lipid domains are classified as 
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detergent-resistant membranes when they are insoluble in cold, nonionic detergents 
(65). 
Cholesterol, phospholipids and glycosylphosphatidylinositolanchored proteins 
concentrate within these lipid domains (66). The acyl side chains of cholesterol and 
phospholipids are highly enriched in saturated fatty acids compared to the 
surrounding regions of the membrane (non membrane lipid micro-domains). The 
enrichment of phospholipids and cholesterol with saturated fatty acids enables the 
lipid membranes to pack closer together. This placement results in lipid-micro-
domains or regions which are structurally more ordered and they contain less fluid 
than the surrounding membrane (67).   
The role of lipid domains in immune system activation was observed in T cell 
signal transduction (68). When T cells interact with antigen presenting cells (APC), 
the T cell receptor clusters within lipid domains to form an immunological synapse, 
which initiates intracellular signaling (69). Stulnig et al. demonstrated in human 
Jurkat T cell lines that n-3 PUFA treatment inhibits T cell activation and 
immunological synapse formation by the displacement from the membrane of the 
linker for activation (LAT) of T cells (70), a protein that plays a role in T cell 
activation, from lipid micro-domains (71).   
Fish oil enrichment of cell culture media or the diet primarily affects the 
composition of phosholipids within the lipid micro-domains of immune cell 
membranes. An increase in unsaturated fatty acids results in increased fluidity of cell 
membranes (72, 73), and PUFA treatment increases the size and distribution of lipid 
domains in HeLa cells (74) by changing the basic properties of cell membranes. 
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Furthermore, treatment of cells with n-3 PUFAs has an effect on acylated 
proteins that are anchored to the inner lipid leaflet by replacing saturated fatty acids 
with unsaturated fatty acids. This effect was demonstrated by the displacement of 
signal molecules expressed on n-3 supplemented Jurkat T cells from the 
cytoplasmic layer of the lipid-micro-domain (46). Moreover, dietary fish oil, as well as 
pure DHA treatment, has been postulated to reduce the susceptibility to autoimmune 
disorders and chronic inflammatory diseases by affecting CD4+ T cell plasma 
membrane fatty acid composition.  Nevertheless, in this study fish oil feeding 
specifically changed the phosphatidylserine and phosphatidylethanolamine fractions 
within CD4+ T cells membranes, while the TCR/CD3 complex was not affected (75). 
These data suggest that the anti-inflammatory properties of n-3 PUFAs may result 
from altered T cell function via the alteration of lipid membrane domain structure.  
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Figure 1.2.6 Schematic representation of a lipid micro-domain and T-cell activation.  
Modified from Hughes DA (76, 77). Green arrows point to potential impact position of feeding n-3 
PUFAs. 
 
1.6 Influenza A virus 
Influenza viruses are membrane enveloped, negative-strand RNA viruses in 
the Orthomyxoviridae family. Influenza viruses are classified as influenza A, B or C, 
based on the antigenic differences of their core nucleoproteins and matrix proteins 
(Figure 1.2.7) (78). The influenza A virus infects host respiratory epithelial cells, is 
highly contagious, and is the most pathogenic of the influenza strain types (79).   
The mouse provides a well characterized model for influenza virus infection 
(80, 81). Following intranasal infection, mouse-adapted strains of influenza virus can 
cause pneumonia, tracheitis, and flu-like symptoms similar to those found in human 
infections (29, 82-84). 
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1.6.1 Structure of Influenza A virus 
 
Influenza A virus RNA is composed of eight RNA segments which encode for 
ten different proteins: envelope glycoproteins hemagglutinin (HA) and 
neuraminidase (NA), matrix protein (M1), nucleoprotein (NP), three polymerases 
(PB1, PB2 and PA), ion channel protein M2, and nonstructural proteins NS1 and 
NS2 (79). Influenza A viruses are classified according to their hemagglutinin (H1–
H15) and neuraminidase (N1–N9) genetic and antigenic types (85). The HA forms a 
spike-like structure on the surface of the virus and binds to the host cell receptor. 
Binding of the virus to the host cell occurs when HA influenza virus particles 
attached to cell surface sialic acid, present on glycoproteins or glycolipids on the 
surface of host cells (86, 87). The specificity of the sialic acid (α-2,6-linked or α-2,3-
linked ) determine species-specific restriction of influenza viruses (88). The NA is 
also expressed on the viral surface and functions to remove sialic acid on host cells 
which then allows for the release from the cell and spread of virus particles 
throughout the body via the blood circulation (87). The viral membrane envelope 
surrounding the viral RNA (vRNP) consists of a lipid bilayer containing spikes 
composed of viral glycoproteins (HA and NA) on the outer side and M1 on the inner 
side (Figure 1.2.6). Viral lipids, derived from the host plasma membrane, are 
selectively enriched in cholesterol and glycosphingolipids that are derived from the 
host plasma membrane (Figure 1.2.7) (87). 
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Figure 1.2.7 Structure of influenza A virus.  
Showing 3 structural proteins: Haemagglutinin (HA), neuraminidase (NA) and matrix protein 
(M2). The ratio of HA to NA molecules in the viral envelope usually ranges from 4:1 to 5:1. 
The influenza virus matrix protein M1 associates inside the viral membrane. The viral 
genome consists of eight negative-strand RNA segments and is packaged into the particle 
as a ribonucleo-protein with nucleocapsid protein (NP) and the viral polymerases PA, PB1 
and PB2. Adapted from Karlsson (89). 
 
 
 
1.6.2 The life cycle of Influenza A  
Influenza A viruses preferentially replicate in host respiratory epithelial cells, 
but macrophages and other leukocytes may also become infected (90). The first 
stage in influenza virus entry to a host cell is the recognition of a terminal sialic acid 
on target cell surface molecules by the viral HA protein (91). Host cell-bound viruses 
are internalized by receptor-mediated endocytosis of cholesterol and 
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glycosphingolipid enriched membrane micro-domains via clathrin-coated pits or 
clathrin-independent endocytosis (92, 93). Following endocytosis, the virus is 
transported to endosomes, where the low pH induces membrane fusion between the 
viral and endosomal membranes. Viral replication is a two-step process that begins 
with a full-length positive-sense copy of the vRNA being transcribed to 
complementary (c) RNA. cRNA is then used as a template to produce additional 
vRNA (Figure 1.2.8) (94, 95). Viral replication and mRNA synthesis depends on host 
cell nuclear function. 
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Figure 1.2.8 The life cycle of influenza A virus.  
Modified from Bao Y (96). 
 
 
1.6.3 PUFA role in interfering with virus budding 
In polarized epithelial cells, influenza A viruses assemble and bud at the apical 
surface of the cells using cholesterol and glycospingolipid enriched membrane 
domains (97, 98). Buds are released by release of the apical membrane and fission 
of the bud from the cell membrane (87). Viruses that bud from the host cell consist of 
18-37% lipids by weight. The composition of viral lipids and host cell membranes are 
similar (99).  
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The composition of the host lipid bilayer affects properties of the virus 
membrane, including virulence, lipid heterogeneity and lipid–protein interaction (92, 
100). Given that Influenza A virus budding relies on the existence of cholesterol and 
glycospingolipid-enriched membrane domains (101, 102), n-3 PUFA enrichment of 
cells has been suggested to interfere with virus-budding and fission processes 
(Figures 1.2.6 and 1.2.9). Unpublished data from our laboratory (Dr. Beck) have 
suggested that the influenza virus becomes “trapped” in PUFA-treated cells when 
compared to non-PUFA treated infected cells. 
Figure 1.2.9 A schematic representation of virus budding.  
Modified from Nayak (87). Green arrows point to potential impact position of feeding n-3 
PUFAs 
 
1.7 Roles of PUFAs in modulating cell responses to influenza infection 
 
Immune responses to influenza virus infection contain virus spread and 
reduce virus infectivity. To do so, the host requires an effective and coordinated 
activation of the innate (early) and adaptive (delayed) immune response.  
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Innate immunity is the first line of defense that restricts influenza viral spread by the 
activation of non-specific immune responses (103). The first step in the innate 
immune response is the release of cytokines and chemokines from virus-infected 
cells (29). The expression and release of these inflammatory mediators induces a 
rapid infiltration of neutrophils, which is followed by infiltration of other inflammatory 
cells such as monocytes, macrophages and natural killer (NK) cells. For example, 
during influenza infection, the influx of immune cells into the lung alveolar space is 
recognized as a key characteristic of the host defense mechanism against viral 
infection (104). Further elimination of virus-infected cells requires cell-mediated 
mechanisms that form the adaptive immune response. In particular, virus-specific T 
cells are essential in this process. Several days after the initial infection are required 
before adaptive immunity becomes effective, as antigen specific T cells have to be 
expanded de novo during a primary infection (29). During the transition time from an 
innate to an adaptive immune response, neutrophils, macrophages, dendritic cells 
(DCs), and NK cells help control viral spread (104).  
Studies of mice fed fish oil enriched diets illustrate, that in response to 
immune system stimulation, the anti-inflammatory properties of PUFAs reduced 
natural killer (NK) cell activity (105), decreased lymphocyte proliferation (55), and 
diminishing antigen presentation by monocytes and dentritic cells (75, 76, 106, 107).  
In addition, decreases in ex vivo production of TNF-α (108), interleukin (IL)-1, IL-2, 
IL-6 and interferon (IFN)-γ, have been reported in cells of mice fed fish oil enriched 
diets (Figure 1.2.10) (42, 109, 110).  
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Figure 1.2.10 A schematic representation of the temporal nature of the host immune response to 
invasion by a pathogenic microorganism 
Modified from Burleson et al (111). Green arrows point to potential impact position of feeding n-3 
PUFAs. 
 
 
1.7.1 Virus infection-induced cytokine responses  
The interferon (IFN) isoforms α and β (IFN α/β), which are primarily 
secreted from virally infected epithelial cells, are the cytokines initially produced in 
response to infections. IFN α/β enhance immune function by up-regulating cytokine 
receptors (112, 113), activating NK cells (114), promoting the differentiation of 
monocytes to DCs (115) and controlling the gene expression of the major 
histocompatibility complex (MHC) (116). The few studies that have investigated the 
effect of n-3 PUFA treatment on IFN α/β secretion found no association (37, 117). 
Interferon-γ (IFN-γ) is synthesized by activated T cells and NK cells in 
response to infection. IFN-γ is associated with upregulation of MHC II expression 
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and is responsible for the activation of macrophages to produce cytokines and 
enhance macrophage-mediated killing of intracellular pathogens (118, 119). With 
influenza infection, IFN-γ production provides a positive feedback loop among 
macrophages, NK cells, and T cells.  
The impact of fish oil feeding on IFN-γ secretion during infection has been 
analyzed. Byleveld et al. showed that influenza virus-infected fish oil fed mice had 
increased virus titers with decreased IFN-γ levels in lungs compared to beef tallow 
fed mice.  The authors suggested that an impaired production of IFN-γ may have 
been responsible for delayed influenza virus clearing in lungs of mice (37). 
Additionally, Fritsche et al. showed that feeding mice a diet rich in n-3 PUFAs from 
fish oil significantly lowered the production of IFN-γ, while bacterial Listeria 
monocytogenes load increased (120). These studies suggested that n-3 PUFA 
impairment of IFN-γ secretion plays a significant role in the clearance of an 
infectious pathogen.  
Influenza virus-infected monocytes contribute to the host response through 
the production of cytokines tumor necrosis factor (TNF)-α, interleukins (IL)-1β, IL-6 
and IFN-α/β (121, 122). TNF-α acts on blood vessels to increase vascular 
permeability to fluids, proteins, and cells and to increase endothelial adhesiveness to 
leukocytes and platelets (123). During viral infection, TNF-α is also produced by 
activated T and NK cells (29, 124).  
The production of IL-1α and IL-1β enhances the immune response by 
increasing the expression of adhesion factors on endothelial cells (125), the 
activation of T cells (126) and the gene expression of cyclooxygenase and 
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phospholipase A2 enzymes (127). IL-1β does not influence the killing of virus-
infected cells directly, but enhances secondary antibody responses and recruits T 
cells to the site of infection (128). Induction of TNF-α and IL-1β results in the 
synthesis of IL-6 from infected monocytes, macrophages and endothelial cells (29). 
IL-6 production during influenza infection has pleiotropic effects, including the 
activation of NK cells and macrophages in addition to stimulation of T-cell 
differentiation (129). IL-6 acts as both a pro-inflammatory and anti-inflammatory 
cytokine and plays a role in haematopoiesis and acute-phase immune responses of 
the host (130). Cell culture studies suggest that n-3 PUFAs play a central role in 
altering cytokine induction. EPA and DHA enrichment of culture medium was shown 
to inhibit the production of endotoxin-induced IL-1β and TNF-α by monocytes (131). 
Additionally, pretreatment with EPA and DHA significantly decreased in vitro TNF-α, 
IL-1β and IL-6 production by lipopolysaccharides (LPS)-stimulated macrophages 
compared to LPS-stimulated macrophages that were not fatty acid pre-treated (132). 
Fish oil feeding in mice reduced LPS-induced production of TNF-α, IL-1β and IL-6 by 
macrophages and decreased TNF-α, IL-1β and IL-6 concentrations in the circulation 
(133, 134). Thus, diets high in n-3 PUFAs, including EPA and DHA may decrease 
inflammatory responses to infection by decreasing the cytokine production of 
mononuclear phagocytic cells, such as circulating monocytes and tissue 
macrophages.   
In addition to the previously mentioned cytokines, influenza virus-infected 
macrophages also secrete chemokines. Chemokines act as chemoattractants that 
enhance the trafficking of immune cells to the site of infection. During viral infection, 
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chemokines additionally stimulate the secretion of cytokines from infected 
monocytes. The chemokines secreted by virus-stimulated macrophages include: 
regulated upon activation normal T cell expressed and secreted (RANTES), 
monocyte chemotactic protein (MCP-1) (135, 136) and macrophage inflammatory 
protein 1α (MIP-1α) (137). Pretreatment with EPA was shown attenuat the up-
regulation of MCP-1 and adhesion molecules in umbilical vein endothelial cells after 
stimulation with TNF-α (138). In other studies, however, the incorporation of n-3 
PUFA into human alveolar epithelial cells had no measurable effect on the 
production of chemokines (i.e. RANTES) in response to respiratory syncytial virus 
infection (139). 
1.7.2 Roles of PUFAs in virus infection-induced cell-mediated responses 
 
T cell activation requires recognition of antigen by the T cell receptor. T cells 
recognize antigen in the context of major histocompatibility complex (MHC) 
glycoproteins presented on the surface. Antigen presenting cells (APCs) (such as 
macrophages and dendritic cells) express MHC class II molecules, whereas all 
nucleated cells express MHC class I molecules. MHC class I molecules present 
antigens to CD8+ T cells and MHC class II molecules present antigen to CD4+ T 
cells (140, 141). 
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Figure 1.2.11 The role of PUFA feeding in clonal expansion of naïve T cells. 
 
Most studies have tested the effects of n-3 PUFAs on MHC class II surface 
expression because MHC class II molecules are up-regulated in many autoimmune 
and inflammatory disorders. These studies show that n-3 PUFA enrichment reduces 
MHC class II surface expression (44, 45, 142). For example, treatment of stimulated 
monocytes with EPA and DHA decreased MHC class II expression and diminished 
the ability of APCs to present tetanus toxoid antigen to lymphocytes (76). In rats, fish 
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oil feeding diminished the expression level of MHC class II and therefore reduced 
the antigen presentation function of dendritic cells (45). Recently, Shaikh et al. 
demonstrated the effect of PUFAs on MHC class I expression and on MHC class I-
mediated antigen presentation. Expression of MHC class I was decreased with in 
vitro treatment of B lymphoblasts (JY cells) with ararachidonic acid (AA) or DHA.  
This study showed that the effect was fatty acid concentration dependent, with AA 
being more effective than DHA. Functionally, the reduced MHC class I expression 
resulted in decreased T cell lysis of the PUFA treated JY cell (143). Thus, because 
fish oil feeding may reduce antigen presentation, adaptive immunity may be 
negatively affected when faced with infectious disease.  
Natural Killer (NK) cells are non-specific cytotoxic lymphocytes activated by 
interferons or macrophage-derived cytokines in response to infection.  NK cells help 
to control viral infections while the adaptive immune system generates a more 
specific antigen response to clear the infection.  NK cells distinguish pathogen 
infected cells from uninfected cells based on recognition of ‘activating’ or ‘inhibiting’ 
receptors (114).  Cytolysis of the target cell occurs following the secretion of 
cytotoxic perforin granzyme B protein that penetrates the targeted cell and leads to 
cell death (144). Studies of cytolysis have compared the effects of fish oil and corn 
oil feeding in mice on NK activity (37, 53, 105, 145-147). These studies 
demonstrated that mice fed fish oil diets exhibited decreased NK activity compared 
with mice on corn oil diets. Considering that NK cells kill virally infected cells and 
represent the first line of the innate immune responses during influenza infection 
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(148), the attenuated inflammatory response due to fish oil has be hypothesized to 
impair viral clearance by NK cells. 
Dendritic cells (DCs) and macrophages are considered antigen presenting 
cells (APCs) and each type forms a bridge between innate and adaptive immunity.  
DCs reside in peripheral tissues, where they survey for incoming pathogens. 
Invading viruses can directly infect DCs, or DCs can phagocytose virus-infected 
apoptotic or necrotic cells.  After viral uptake, DCs migrate from the infected tissue to 
draining lymph nodes, where they present viral antigens to T cells. DCs modulate 
immune responses to infection by the secretion of IL-12, which acts on CD8+ T cells 
to augment cytolytic activity and IFN-γ production (149-151). Additionally, DCs 
produce IFN α/β, which, together with the production of IL-12, enhances NK cell 
expansion and activation (30). Sanderson et al. demonstrated that dietary fish oil 
diminished the antigen presentation of rat dendritic cells because fish oil feeding 
significantly diminished the levels of adhesion molecules and MHC class II 
expression on dendritic cells (45). The diminished APC function of DCs that 
accompanies fish oil feeding suggests that, upon infection, fish oil feeding would 
result in decreased elimination of virus-infected cells and/or an altered antigen 
presentation to T cells. 
1.7.3 PUFAs role in clonal expansion of T cells  
Clonal expansion of T cells is an essential process in cell-mediated immunity 
(152). T cells mediate regulatory and effector functions through the expansion and 
differentiation of T cells expressing surface protein CD4 or CD8. One of the 
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important immunomodulatory activities of n-3 PUFAs is their ability to diminish T cell 
differentiation and proliferation (60, 153). 
As circulating T cells migrate from the thymus through peripheral lymphoid 
tissues, T cells sample MHC-peptide complexes on antigen presenting cells (Figure 
10) (140, 141).  If the T cell receptor (TCR) recognizes the antigen presented by the 
MHC, then clonal expansion, differentiation and activation is triggered. T cells 
recognize antigens by the TCR. When the TCR recognizes antigens, an activation 
signal is transmitted by the CD3 complex on the T cell (154). Upon the initial 
encounter with antigen, naïve T cells produce IL-2. The antigen recognition by TCR 
and the induction of IL-2 by naïve T cells leads to rapid clonal expansion and 
differentiation of T cells, which are unique to specific antigen presented to them.  
CD4+ T helper cells. T cells expressing the surface protein CD4 (CD4+ T cell) 
can further be differentiated into a T helper cell (Th1) or Th2 phenotype. Th1 or Th2 
subtypes are determined by the type of invading pathogen and the cytokines 
secreted during CD4+ T cell activation. When naïve T cells recognize antigens, which 
are presented by APC’s, then T cells are also exposed to IL-12. IL-12 promotes the 
differentiation of the T cell into the Th1 subset, which then produces IFN-γ, which 
primarily interferes with viral infection and stimulates phagocyte-mediated killing. If 
the invading pathogen does not elicit IL-12 production by APC’s, then T cells 
themselves produce IL-4, which induces the differentiation of these cells towards the 
Th2 subset (155).  Th2 cells produce cytokines IL-4 and IL-5, which stimulate 
phagocyte-independent mediated immunity. Some of the cytokines produced by Th2 
cells, such as IL-4, IL-10, and IL-13, additionally inhibit macrophage activation and 
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suppress Th1 cell-mediated immunity (156). The Th1 cell responses help to activate 
CD8+ cytotoxic T cells and are important for dealing with viral infection. Th2 
responses provide help for B cells to enhance antibody production and activate 
eosinophils (140). 
Since dietary n-3 PUFAs can alter cytokine induction, it has been suggested 
that the anti-inflammatory effects of fish oils may be due to their ability to modulate 
the Th1/Th2 balance (60, 106). For example, Fritsche et al. demonstrated that n-3 
PUFA consumption was associated with a significant impairment of in vivo IL-12 
production in mice. Fritsche et al. suggested that the attenuated inflammatory 
response seen with fish oil feeding may be explained, at least in part, by 
suppression of a Th1 response (120). Zhang et al. illustrated that dietary n-3 PUFAs 
inhibited the proliferation of both antigen-stimulated CD4+ T cells and the IL-2 
induced proliferation of antigen-specific Th1 cells. His group concluded that dietary 
n-3 PUFAs inhibited Th1 cell responses by suppressing the clonal expansion of Th1 
cells (106, 157). Furthermore, during influenza virus infection, cytokine IL-12 and 
IFNγ production by CD4+ T helper cells activate CD8+T cells (141). Because n-3 
PUFAs are able to suppress Th1 responses they also may impair CD8+ T cell 
function. 
CD8+ T cytotoxic cells. Successful host defense against intracellular 
pathogens involves activation of phagocytes and the generation of cytotoxic CD8+ T 
cells. Upon encountering an antigen, CD8+ T cells produce IFN-γ, which inhibits viral 
replication by several mechanisms. The production of INF-γ increases expression of 
MHC class I on the cell surface, increases antigen presentation by macrophages, 
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increases NK cytotoxic activity and enhances adhesion expression that are 
necessary for leukocyte migration, together these immune responses to INF-γ can 
lead to a suppression of Th2 cell activity (118). CD8+ cells, additionally, eliminate 
virally infected cells through direct lysis of targeted cells (158). In mice that lack 
CD8+ cells (CD8 -/-), infection with influenza A/PR/8/34 (PR8) led to increased viral 
replication and mortality (159). In contrast, CD4 -/- mice effectively cleared PR8, 
implying that CD4+ T cells are not required for elimination of influenza infection (160). 
Few studies have examined the effects of n-3 PUFAs on CD8+ cytotoxicity and/or 
CD8+ T cell proliferation and T cell trafficking (161, 162). Most of these studies 
investigating the antigen-driven expansion of CD8+ T cells reported that antigen-
specific CD8+ T cells were unaffected by n-3 PUFAs (163).   
In summary, immune responses to influenza virus infection aim to restrain 
virus spread and control virus infectivity. Because n-3 PUFAs have been shown to 
decrease inflammatory responses such as the production of cytokine (41, 42), 
natural killer cell activity (43), antigen presentation (44, 45), lymphocyte function, 
and T cell responses (46, 47) the inflammation due to infection, may not be induced. 
Thus, n-3 PUFA feeding may have profound effects when combating an infection in 
which an intact immune response is necessary to eliminate the pathogen. 
1.8 Dietary n-3 PUFAs and reduced resistance to pathogens 
Publications that have investigated the influence of n-3 PUFAs on infectious 
disease resistance in mice are summarized in Table 1.1. Most studies examined the 
effects of the immune response in mice to bacterial challenges and found host 
survival to be dependent on the type of pathogen. For example, PUFA-fed mice 
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challenged with Listeria monocytogenes and Pseudomonas aeruginosa had less 
survival than those fed other types of fat (38, 164). In contrast, other studies 
demonstrated that fish oil feeding did not affect resistance of mice to bacteria such 
as Salmonella typhimurium and viral challenges such as Cytomegalovirus and 
Influenza A/Queensland. Other studies have shown that dietary fish oil can enhance 
mouse survival to Klebsiella pneumoniae and mouse AIDS virus (Table 1.1). Only 
one of these studies examined the effects of PUFAs in mice infected with influenza 
virus. 
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Table 1.1 N-3 fatty acids and infectious disease resistance.  
Modified from Anderson et al (2). 
Mouse 
sex and 
strain 
Pathogen and 
dose 
Site of 
infection 
Dietary 
treatment 
Duration 
(165) 
Survival of 
control vs. 
fish oil 
diet 
Authors 
Viruses 
Male 
BALB/c 
Influenza 
A/Queensland/6/
72 (H3N2)  
log10 5 CFU 
Intranasal 6% sunflower 
oil with 34% 
beef tallow or 
34% fish oil 
2 
 
No 
change 
Byleveld 
et al. (37) 
Female 
C57BL/6  
Mouse AIDS 
(MAIDS ) 
LpBMS MuLV  
5 X IO5 PFU 
Intra 
peritoneal 
(i.p)  
5% corn 
oil (CO), 5% 
CO with 40% 
energy 
restriction or 
20% Fish oil 
4 Increased Fernandes 
et al. (166) 
Female 
NZBxW  
Cytomegalovirus 
(CMV)  
104-107 CFU 
 i.p. 46% beef 
tallow or 46% 
menhaden fish 
oil 
4-5 No 
change  
Rubin et 
al. (167) 
Bacteria 
Female 
NZBxW 
Pseudomonas 
aeruginosa 
105-109 CFU 
i.p. 46% beef 
tallow or 46% 
menhaden fish 
oil 
4-5 No 
change  
Rubin et 
al. (167) 
Female 
CF1  
Salmonella 
typhimurium 
104 CFU 
i.p. 40% coconut 
oil, safflower 
oil, MaxEPA 
mix 
2-3 No 
change 
Clouva-
Molyvdas 
et al.(168)  
Female 
C57Bl/6 
Klebsiella 
pneumonia 
0.5x104-5 
Intra 
muscular 
(i.m.) 
30% corn oil 
30% plam oil 
28% fish oil 
(+2% corn oil) 
6 Increase Blok et al. 
(169) 
Female 
BALB/c 
Pseudomonas 
aeruginosa 
~105 CFU 
Burn side 10 and 40% 
safflower oil or 
MaxEPA mix 
2-3 Decrease Peck et 
al.(164) 
Female  
C3H/He
N 
Listeria 
monocytogenes 
105-107 CFU 
 i.p. 20% lard, 
soybean oil or 
17% 
menhaden fish 
oil (+ 3% corn 
oil) 
4-5  Decrease
d 
Firtsche et 
al. (38) 
Sex not 
reported 
BALB/c 
Listeria 
monocytogenes 
105 cfu 
i.p. Low fat as 
control, 20% 
coconut oil, 
olive oil, fish oil 
4 Decrease
d 
Puertollan
oet al. (39) 
Female 
swiss 
webster  
Salmonella 
typhimurium 
 6 x 106 CFU 
i.p. 20% 
menhanden 
fish oil  
4 Decrease
d 
Chang et 
al.(40)  
Male 
C57BL/6  
Pseudomonas 
aeruginosa 
2 x 105 cfu 
Trans-
tracheal 
insertion 
fatty acid 
mixtures  
EPA 10% 
DHA 5% 
5 Increased Pierre et 
al. (170) 
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With the anticipated increase of fish consumption and the increase in the 
usage of fish oil supplements per person, there is growing concern that the 
beneficial anti-inflammatory properties of n-3 PUFAs that prevent chronic 
inflammatory illnesses may have adverse effects when inflammation is necessary to 
combat infection (2, 4, 171).   
To date, limited data have reported the effects of fish oil supplementation on 
the progression of virus infections (2, 37, 167, 172). More information is needed on 
how increased fish oil intake affects the immune response to infection. We chose the 
influenza virus as a model system to study the effects of PUFAs on infection 
because its infectivity is well characterized in animal models and, therefore this 
model has applications to human infectious with this virus. 
1.9 Limitations of studying the immunomodulatory effects of PUFAs  
The ability of PUFAs to influence the immune system has been established 
(117).  Much of what is known about the immunosuppressive effects of PUFAs on 
inflammatory illnesses has come from feeding studies, but results have been highly 
variable.  Human dietary studies rarely exceed 3 to 4% of n-3 PUFA total energy 
intake, whereas most animal studies used percentage of n-PUFAs that exceed what 
is possible in humans, even for those consuming n-3 PUFA supplements (Table 1.1) 
(49). Another recurring problem with these studies is the choice of appropriate 
control diets. When selecting a control diet for studying the influence of PUFA, its is 
important to consider equivalent amounts of total dietary calories obtained from 
protein, carbohydrates and fats in addition to the vitamin mix and mineral content 
used. Suitable control diets should include all components of the treatment diet in 
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the same amounts expect the dietary component in question. Therefore, only 
chemically defined diets are appropriate. 
The advantage of using animal feeding studies is that they are of physiological 
relevance and can control for genetic variability. Compared to cell culture 
experiments, animal studies often avoid “cell culture artifacts” that can alter 
characteristics from the original cell population (6, 173). Animal experiments are 
preferred, but results may not be consistent. Factors which may influence 
experimental may include the 1) limited number of studies, 2) nature of the 
pathogen, 3) challenge dose administered, 4) route of administration, 5) genetic 
background and sex of the animal, 6) length of feeding before the immune challenge 
and, 7) specific n-3 PUFAs fed. 
Because this study was designed to test if fish oil feeding can modulate the 
immune response to influenza virus infection, we chose an animal model to reflect 
as close as possible human conditions with a dietary intervention and use of 
infectious challenge. The treatment diet consisted of a natural fatty acid mixture that 
provided 4% menhaden fish oils (+ 1% corn oil) at physiologically achievable levels 
of n-3PUFAs, rather than pharmacological concentrations. A two week feeding 
period before the immune challenge was chosen based on prior feeding studies (2, 
49, 74, 106, 157). The influenza virus was administered intra-nasally, which 
represents the most natural route of administration. Much of what is known about 
how PUFAs modulate the immune system stems from in vitro studies employing 
nonspecific polyclonal activators, and in vivo studies are often limited to bacterial 
infection (2). The strength of our in vivo study is that we analyzed a wide range of 
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immune cells involved in innate and adaptive immunity and also measured these 
variables during the recovery phase from virus infection.   
Beneficial anti-inflammatory properties of fish oil feeding were found to protect 
mice from lung inflammation, although these same properties can adversely affect 
overall immune function when the body needs to fight an acute infection.  Given that 
n-3 PUFA-rich fish oil capsules are readily available and the supplemental inclusion 
of n-3 PUFAs in prepared foods is on the rise, the understanding of how PUFAs can 
affect the immune response to infection becomes even more important. Better 
dietary recommendations for the public can be made only after detailed 
understandings of PUFAs in modulating innate and adaptive immunity are achieved. 
The next two chapters represent manuscripts that will be submitted for 
publication or are already under review. The final chapter provides a general 
summary of the results of the experimental studies and suggestions for future 
investigation. 
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CHAPTER II 
2 Impaired resistance to influenza infection in fish oil fed mice 
 
Nicole MJ Schwerbrock, Erik A Karlsson, Qing Shi, Patricia A Sheridan, Melinda A 
Beck.   
Manuscript submitted March 26, 2009 to Journal of Nutrition 
2.1 Abstract 
Dietary fish oils, rich in n-3 polyunsaturated fatty acids (PUFA), including 
eicosapentaenoic acid and docosahexaenoic acid (DHA), have been shown to have 
anti-inflammatory properties. Although the anti-inflammatory properties of fish oil 
may be beneficial during a chronic inflammatory illness, the same anti-inflammatory 
properties can suppress the inflammatory responses necessary to combat acute 
viral infection. Given that n-3 PUFA-rich fish oil supplementation is on the rise and 
with the increasing threat of an influenza pandemic, we tested the impact of fish oil 
feeding for 2 weeks on the immune response to influenza virus infection. Male 
C57BL/6 mice fed either menhaden fish oil (4:1, w/w at 5g/100g) or a control corn oil 
diet were infected with influenza A/PuertoRico/8/34 and analyzed for lung pathology 
and immune function. Although fish oil fed mice had a reduction in lung inflammation 
compared to controls, fish oil feeding also resulted in a 4-fold increase in mortality, a 
7-fold increase in lung viral load at d 7 post infection and a prolonged recovery 
period following infection. While splenic natural killer (NK) cell activity was 
suppressed in fish oil fed mice, lung NK activity was not affected. Additionally, lungs 
of infected fish oil fed mice had significantly fewer CD8+ T cells and decreased 
mRNA expression of MIP-1α, TNF-α and IL-6. These results suggest that the anti-
inflammatory properties of fish oil feeding can alter the immune response to 
influenza infection resulting in increased morbidity and mortality.  
2.2 Introduction 
Dietary long chain polyunsaturated fatty acids (PUFA) derived from fish oil have 
been shown to have beneficial effects on chronic inflammatory and autoimmune 
disorders, suggesting that fish oil has anti-inflammatory and immunomodulatory 
properties (4, 5). Abundant in marine fish oils, long chain PUFA of the omega-3 
series such as eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid 
(DHA; 22:6n-3), appear to be most beneficial (7, 174). A number of studies report 
that the immunosuppressive effects of PUFAs are a result of decreased cytokine 
production and from reductions in T cell proliferation, activation, and signaling (41, 
47, 175). Studies of rodents fed with fish oil enriched diets have shown a reduction 
in natural killer (NK) cell activity (105), decreased lymphocyte proliferation (106, 109) 
and decreased antigen presentation functions (6, 106, 176, 177).  In addition, 
decreases in ex vivo production of tumor necrosis factor-α (TNF-α), interleukin (IL)-
1, IL-2, IL-6 and interferon (IFN)-γ, have also been reported (109, 133, 134, 178, 
179)   
While the anti-inflammatory properties of PUFA may be beneficial for some 
chronic inflammatory illnesses, these same anti-inflammatory properties may be 
detrimental for response to an infection when an intact immune system is needed to 
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eradicate an invading pathogen. For example, diets supplemented with fish oils have 
been shown to lower host resistance to Mycobacterium tuberculosis (14), to reduce 
the survival of mice against infection with Listeria monocytogenes (38, 39) and to 
decrease resistance of mice infected with Salmonella typhimurium (40).  Similarly, 
fish oil feeding can diminish host defense against influenza virus due to delays in 
viral clearance (37). 
 Despite the availability of vaccines and antiviral agents, influenza virus 
continues to be a major cause of morbidity and mortality worldwide (32, 34). 
Influenza virus infects cells of the respiratory system resulting in an acute and 
diffuse inflammation of the bronchoaveolar tract (29). Following infection, a 
coordinated immune response consisting of both innate and adaptive mechanisms 
results in an accumulation of immune cells and secretion of immunomodulatory 
proteins designed to limit viral spread. In the mouse model of influenza virus 
infection, NK cells, neutrophils, and T lymphocytes increase in the lung post infection 
and contribute to host protection (180). The secretion of both inflammatory and 
antiviral cytokines helps to eliminate the virus and reduce further spread. While this 
inflammatory response is necessary for viral clearance, it also contributes to lung 
pathology (180). Although there are many studies documenting the anti-
inflammatory properties of fish oil, there are few studies that examine the effects of 
fish oil on viral infection (2).  
Because of the known health benefits, fish oil supplementation is on the rise. 
A survey conducted among health care professionals reported an increase in fish oil 
supplementation from 24% to 30% in 2006 to 2007 (27). Additionally, in 2007, 37.4 
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%  of the US population reported using fish oil or fish oil supplements for health 
reasons (181).  With the anticipated increase of fish consumption and the increase in 
the usage of fish oil supplements per person, there is a growing concern that the 
beneficial anti-inflammatory properties of n-3 PUFAs may have adverse effects 
when inflammation is necessary to combat infection (2, 4, 171). This study was 
undertaken to investigate effects of fish oil feeding on the immune response to 
influenza virus infection in mice.   
2.3 Materials and Methods 
Animals and diet: Six-week-old male C57BL/6J mice were purchased from Jackson 
Laboratories. All mice were housed at the University of North Carolina Animal 
Facility, which is fully accredited by the American Association for Accreditation of 
Laboratory Animal Care. Animals were maintained under protocols approved by the 
Institutional Animal Care and Use Committee. All mice were housed under a 12 hour 
light/dark schedule with free access to food and water. Mice were fed ad libitum a 
control semipurified diet containing 5% corn oil (D07092502, Research Diets, Inc) or 
a fish oil-corn oil diet at physiologically levels (1% corn oil + 4% fish oil, D07092503, 
Research Diets, Inc) for 2 weeks (Table 2.1). Fish oil diet was supplemented with 
0.405 g/kg Vitamin E to keep normal Vitamin E levels during infection (182, 183) .  
Virus and infection: The mouse-adapted strain of influenza A/Puerto Rico/8/34 
(A/PR8, American Type Culture Collection) was propagated in the allantoic fluid of 
10-day-old fertilized hen’s eggs, and the viral titer was determined by 
hemagglutination assay (184). Following 2 weeks dietary treatment, mice were 
anesthetized with an intraperitoneal injection of a ketamine (0.6 mg/kg)/xylazine 
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(0.35 mg/kg) solution and infected intranasally with 0.05 mL of 2 hemagglutinating 
units of A/PR8 virus diluted in PBS. Previous studies from our laboratory determined 
that this dose of virus is sufficient to effectively elicit an immune response with 
normal mortality in mice (184). Mice were weighed daily following infection and 
percent weight loss compared to starting weight at time of infection was calculated.  
Pathology: The left lobe of the lung was removed at day 0 (uninfected mice) 3, 7, 
10, 15 and 21 post infection (p.i) and perfused with 4% paraformaldehyde, paraffin 
embedded, cut in 6 µm sections, and stained with hemotoxylin and eosin.  Pathology 
grading was performed semiquantitatively according to the relative degree of 
inflammatory infiltration as previously described (185). 
Quantification of lung virus titer: As previously described, lung viral titers were 
determined by a modified tissue culture infection dose 50 (TCID50) using 
hemagglutination as an endpoint (184) . Briefly, supernates from lung homogenates 
were serially diluted and used to infect Madin-Darby canine kidney cells. Virus titers 
were determined based on the presence or absence of hemagglutination of human 
O red blood cells and TCID50 was determined by the method of Reed and Muench 
(186). 
Enumeration of NK cell populations: Lungs and spleens were removed at d 0 and 
3 p.i. Lungs were incubated in a collagenase solution (1500 units/ lung) for 1 h. Lung 
and spleen were processed into single cell suspensions using a stomacher (Seward, 
West Sussex, UK) and strained through a 40 µm nylon filter.  Cell numbers between 
different samples were equalized to 5x105 cells/sample and stained with flourescein 
anti-DX5 isothicyanate (FITC) and anti-CD3 phycoerythrin (PE) (BD Pharmingen). 
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Fluorescence was measured using a FACSCalibur flow cytometer (Becton 
Dickinson, San Jose, CA) equipped with a 488 nm argon laser and a 647 nm diode 
laser. The lymphocyte population was gated and NK cells were identified as CD3–
DX5+ within the gate.  
Determination of natural killer cell cytotoxicity: Total lung and spleen cells were 
analyzed using a standard chromium-51 release assay in triplicate following a 
previously published method (184). Percent specific lysis was calculated by the 
following equation: 
 
cpm [sample] – cpm [spontaneous release] 
cpm [maximum release] – cpm [spontaneous release] 
% specific lysis 
Quantification of immune cells: To obtain bronchoaveolar lavage fluid (BALF) 
whole lungs were lavaged three times with PBS at d 3, 7, 10 and 15 p.i. Red blood 
cells were lysed using ACK lysis buffer (0.15mol/L NH4Cl, 1 mmol/L KHCO3, 
0.1mmol/L Na2EDTA in ddH2O, pH 7.4). Samples were washed twice in PBS/2% 
bovine serum, and stained with fluorescent antibody for 30 min on ice, followed by 
three additional washes in PBS/2% bovine serum. At least 5x105 cell suspensions 
were stained with the following anti-mouse monoclonal antibodies: FITC anti-CD3, 
APC-anti-CD4 and PerCP anti-CD8, PE anti-CD11b and FITC anti-GR-1 (BD 
Biosciences). Cell populations were analyzed using a FACSCalibur flow cytometer 
(Becton Dickinson, San Jose, CA). T cells were identified using the follow antibodies: 
FITC-anti-CD3, APC-anti-CD4 and PerCP-anti-CD8 and neutrophils: PE anti-CD11b 
and FITC anti-GR-1(187).  
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Quantitation of lung mRNA cytokine levels: The right lobe of the lung was 
removed at d 0 (uninfected), 3, 7 and 10 p.i. Total RNA was isolated using the 
TRIzol method and reverse transcription was carried out with Superscript II First 
Strand Synthesis kit (Invitrogen). Following previously described methods (184), 
mRNA levels were measured for tumor necrosis factor α (TNF-α), interleukin (IL)-2, 
IL-6, IL-12, interferon-α and IFN-β, regulated upon activation, normal T cell 
expressed and secreted (RANTES), macrophage inflammatory protein-1 alpha (MIP-
1α) and glyceraldehyde-3-phosphate dehydrogenase (G3PDH) using quantitative 
real time polymerase chain reaction. All data were expressed as fold change from 
uninfected mice of the matching diet group. There were no significant differences 
between control and fish oil fed mice with respect to G3PDH levels at any time point. 
All data were expressed as fold change from uninfected mice of the matching diet 
group.  
Statistical analysis: Statistical analyses were performed using JMP 7 Statistical 
Software and SAS 9.1 software (SAS Institute). Normally distributed data were 
analyzed by 2-way ANOVA with diet and day post infection as main effects. 
Student's t test was used for post-hoc comparison between the dietary groups and 
Tukey's HSD was used for post-hoc comparisons among the days p.i. 
Nonparametric data were analyzed using the Kruskal Wallis test. Counted data were 
analyzed using logistic regression analysis p < 0.05 when Wald confidence interval 
for odds ratios did not include 1. Survival data were analyzed using the Kaplan-
Meier survival estimates. Significance that compare the survival curve estimates of 
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the two diet groups were analyzed by the log Rank test.  Differences were 
considered significant at P < 0.05.  
Table 2.1 Composition of experimental diets, including fatty acid composition. 
 Control1 Fish Oil2 
Ingredient g/kg kcal% g/kg kcal% 
Casein 200 800 200 800 
DL-Methionine 3 12 3 12 
Corn Starch 219 876 219 876 
Sucrose 420 1680 420 1680 
Cellulose, BW 60 0 60 0 
Corn Oil 50 450 10 90 
Fish Oil 0 0 40 360 
t-BHQ 1.008 0 1 0 
Mineral Mix 
S10001 
35 0 35 0 
Vitamin Mix 
V10001 
10 40 10 40 
Choline 
Bitartrate 
2 0 2 0 
Vitamin E, 
Acetate (500 
IU/g) 
0 0 0.405 0 
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1 Formulated and supplied from Research Diets, Inc. (D07092502) containing corn oil. 
2 Formulated and supplied from Research Diets, Inc. (D07092503) containing menhaden oil with 
2.1% AA, 14.2% EPA and 12.2% DHA 
2.4 Results 
Fish oil fed mice recover more slowly from influenza virus infection. In mice, 
weight loss is a marker for illness severity following influenza infection and 
subsequent weight gain is an indicator for recovery. To determine if fish oil feeding 
influences body weight following influenza virus infection, mice were weighed daily 
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post infection. Both control and fish oil fed mice lost significant amounts of weight 
during the course of infection. Control mice began to regain weight after d 10 p.i.; 
however, fish oil fed mice did not begin to regain weight until d 14 p.i. By d 20 p.i., 
the body weights were not different between groups (Fig. 2.1). 
Figure 2.1 Percent body weight change following influenza infection.  
Values are expressed as means ± SEM, n = 9-23 per group per time-point. *P < 0.05, control diet 
versus fish oil diet. 
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Fish oil feeding results in a higher mortality rate following influenza infection.  
Increased severity of infection in the fish oil fed mice was also reflected in the 
mortality rates. Beginning at d 11 p.i., fish oil fed mice had a significantly higher 
mortality rate compared to control fed mice. At d 20 p.i., the fish oil fed mice had a 
51% mortality rate compared to a 10% mortality rate in control diet fed mice (Fig. 
2.2). 
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Figure 2.2 Percent survival following influenza infection.  
n = 9-23, per group per time point.   
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Fish oil feeding improves lung pathology post influenza virus infection. 
Influenza virus infection results in a significant infiltrate of inflammatory cells in the 
lung. To determine if the anti-inflammatory properties of a fish oil enriched diet could 
decrease this inflammation, lung pathology was examined at various times p.i. As 
shown in Fig. 2.3, lung pathology was significantly reduced in influenza-infected fish 
oil fed mice at d 7, 10, 15 and 21 p.i. compared to infected control fed mice. 
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Figure 2.3 Degree of lung pathology following influenza infection.   
Values are expressed as means + SEM, n = 4-10 per group per time-point. * P < 0.05, control diet 
versus fish oil diet. 
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Fish oil feeding increases virus load in the lung post infection. Because the fish 
oil fed mice had reduced inflammation in the lungs and the inflammatory response is 
necessary for viral control, lung viral titers were measured in the mice. By d 7 p.i., 
fish oil fed mice had a 7.1- fold increase in viral load versus controls (Fig. 2.4).  
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Figure 2.4 Lung influenza viral titers in control and fish oil fed mice during influenza infection.  
Data are expressed as means + SEM, n = 5-10 per group per time point. *P < 0.05, control diet 
versus fish oil diet.  
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Fish oil feeding affects NK cell cellularity and cytotoxicity. NK cells represent 
the first line of defense post influenza infection (148). Previous studies have 
demonstrated reduced NK activity with fish oil feeding (105). At d 3 p.i., the splenic 
NK population was significantly reduced in the fish oil fed mice compared to controls 
(Fig. 2.5A). In addition, splenic NK activity was also reduced in the fish oil fed mice 
(Fig. 2.5B). In the lungs at d 3 p.i., the fish oil fed mice had less then half the total 
number of NK cells compared with control mice (Fig. 2.5C); however, lung NK 
activity did not differ between groups (Fig. 2.5D).   
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Figure 2.5 Effect of influenza infection and fish oil feeding on NK cells. 
spleen NK cell number (A), spleen NK cell cytotoxicity (B), lung NK cell number (C), and lung NK cell 
cytotoxicity (D). Flow cytometry was used to identify NK cells. The lymphocyte population was gated 
and NK cells were identified as CD3-DX5+.  NK cell activity was analyzed in a standard NK cell 
cytotoxicity assay. Values are means ± SEM, n = 6 per group. *P < 0.05, control diet versus fish oil 
diet. 
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Fish oil feeding reduces neutrophils in lung of infected mice. Recruitment of 
neutrophils to the site of infection is an essential early component of the immune 
response to influenza infection (188). In the lungs of fish oil fed uninfected mice (d 
0), there was a 71% reduction in total neutrophil number compared to control fed 
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mice (Fig. 2.6). Following infection, neutrophil numbers in the lung increased for both 
control and fish oil fed mice; however, the total neutrophil number remained 
significantly lower in the fish oil fed mice. Influenza infected control diet fed mice had 
a significant 2.94-fold increase in neutrophils at d 3 p.i while fish oil fed mice had a 
significant 3.7-fold increase in neutrophil post infection.  
Figure 2.6 Effect of fish oil feeding on neutrophil infiltration of the lung.  
Populations of neutrophils in lung were identified by flow cytometry based on CD11b+ GR-1+ 
expression. Values are means + SEM, n = 5-6. Means for a group without commune letter calculated 
with logistic regression analysis, *P < 0.05. 
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Fish oil feeding reduces CD8+ trafficking to the infected lung. To determine if 
fish oil feeding can decrease T cell trafficking to the lung, total numbers of T 
lymphocytes (CD3+) as well as CD4+ and CD8+ populations were identified in the 
lung following influenza challenge. Although the CD3+ T cell number peaked at d 10 
p.i in both diet groups, fish oil fed mice had a significant decrease in CD3+ T cells at 
days 7 and 10 p.i. (Fig. 2.7A). This reduction in CD3+ T lymphocytes was due to 
decreased numbers of CD8+ T cells (Fig. 2.7B), as the number of CD4+ T cells was 
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not different at any time point (data not shown).  By day 15 p.i., lymphocyte numbers 
were not different between groups.   
Figure 2.7 Effect of fish oil feeding on CD3+ and CD8+ T cell infiltration of the lung.  
Lung cell population of CD3+ lymphocytes (A) and CD8+ cytotoxic T cells (B) in the lungs at days 7, 
10 and 15p.i. Values are means + SEM, n = 5-6. *P < 0.05, control diet versus fish oil diet.  
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Fish oil feeding decreases cytokine and chemokine mRNA expression in lungs 
of influenza infected mice. A coordinated production of cytokines and chemokines 
is produced in the lungs during an influenza virus infection (180). In order to 
determine if fish oil feeding could influence production of these inflammatory 
mediators, mRNA levels were measured for various cytokines and chemokines. Fish 
oil feeding resulted in significantly reduced mRNA expression of MIP-1α , TNF-α, 
and IL-6 at d 7 p.i. compared to controls (Fig. 2.8 A,B,C). Levels of mRNA for IL-2, 
IL-12, IFN-α, IFN-β and RANTES were not different between groups at any time 
point post infection (data not presented). 
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Figure 2.8. Effect of fish oil feeding on mRNA levels of pro-inflammatory cytokines.  
Lung mRNA levels for MIP-1α (A), TNF-α (B) and IL-6 (C). Values are normalized to G3PDH and are 
expressed as fold increase over uninfected mice of the matching diet group. Values are means + 
SEM, n = 4-6, per group per time-point. *P < 0.05, control diet versus fish oil diet. 
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2.5 Discussion 
 The favorable effects of dietary fish oils stem from the potential of n-3 PUFA 
to reduce excessive inflammation (1, 174). Studies have shown beneficial anti-
inflammatory properties of dietary fish oils on chronic diseases such as rheumatoid 
and osteoarthritis, inflammatory bowel disease, cardiovascular disease, type 2 
diabetes and Alzheimer’s disease (12).  However, suppression of the immune 
system may be deleterious when inflammation is required to eliminate the invading 
pathogen, such as during influenza virus infection (2). Following infection with 
influenza, a controlled and coordinated immune response is essential for resolving 
the infection. The availability of n-3 PUFA-rich fish oil supplements and the 
increasing inclusion of n-3 PUFA in prepared foods (189) add to the importance of 
understanding how the immunosuppressive properties of fish oils may impact the 
host’s ability to respond to influenza virus infection.  
 Mice fed a fish oil rich diet had decreased lung pathology following influenza 
infection compared to controls; however, the fish oil fed mice also had a prolonged 
recovery time, significantly increased viral titer and importantly, a significantly higher 
mortality rate. Thus, in the case of influenza virus infection, reduced lung 
inflammation was associated with a poor outcome post infection. In order to 
understand the direct impact of fish oil feeding on the immune response to influenza 
virus infection, numbers and phenotypes of cells infiltrating the lung tissue were 
measured. At d 3 p.i., mice had reduced numbers of NK cells infiltrating their lungs 
compared with control mice. NK cells provide an early defense against influenza 
virus infection and are important in reducing viral load prior to activation of the 
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adaptive immune response (148). NK cell trafficking to the site of infection is 
dependent on a variety of inflammatory mediators, including the expression of a 
cytokine/chemokine gradient, up-regulation of adhesion molecules and activation of 
G-protein-coupled receptors (190-192). n-3 PUFAs have been shown to decrease 
surface expression of vascular adhesion molecules and to alter G-protein-coupled 
membrane receptors (1, 193, 194) suggesting that fish oil feeding may have 
interfered with the signaling required for NK cell trafficking into the lungs. 
 Although the NK cell number was reduced in both the spleen and lungs of fish 
oil fed mice, impairment in NK activity was found only in splenic NK cells. The 
differences between spleen and lung NK activity may be due to exposure to 
cytokines.  There are a number of cytokines that enhance NK cytotoxicity, including 
IL-12, IL-18 and IFN-α and β (148, 191), therefore NK activity in the lungs of fish oil 
fed mice may be increased due to exposure to the cytokine milieu at the site of 
infection. During influenza virus infection, production of inflammatory cytokines 
occurs at the site of infection and therefore the spleen is not exposed to this 
localized inflammatory response. Indeed, Yaqoob et al.  demonstrated enhanced NK 
activity in PUFA treated NK cells following exposure to INF-γ (105).  
  In addition to altered NK cell trafficking, fish oil feeding also affected 
trafficking of neutrophils to the lung following infection. During early virus induced 
inflammatory responses, neutrophils rapidly traffic to into infected airways where 
they play a critical role in limiting virus replication and activating innate immunity 
(188, 195). Neutrophil migration is controlled, in part, by the release of chemokines, 
cytokines and leukotrienes. MIP-1α has been shown to play a critical role in each 
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aspect of neutrophil trafficking, including rolling, stationary adhesion tissue 
recruitment in vivo (196, 197). In addition, studies by Ramos et al. demonstrated that 
ovalbumin (OVA) induced neutrophil migration in immunized mice was mediated by 
MIP-1α via the release of TNF-α and LTB4 (198). Moreover, influenza infected MIP-
1α knockout mice exhibited reduced lung inflammation and delayed viral clearance 
compared with infected wild type mice (199). In our study we show that fish oil fed 
mice lacked MIP-1α and TNF-α mRNA induction. Together, these data suggest that 
the failure to up-regulate MIP-1α and TNF-α mRNA in fish oil fed mice may have 
resulted in reduced neutrophil trafficking to the lungs following influenza infection.  
 On days 7 and 10 p.i., CD8+ T cells were decreased in the lung of influenza 
infected fish oil-fed mice. Influenza-specific CD8+ T cells kill infected target cells by 
direct lysis and also play an essential role in influenza virus clearance and 
controlling morbidity (200-202). In mice that lack CD8+ T cells, infection with 
influenza A/PR/8/34 led to increased viral replication and mortality (159). CD4+ T 
cells, on the other hand, help to resolve inflammation during influenza infection; 
however they are not essential for virus clearance (141, 203). Our data suggests 
that reduction in CD8+ T cell number post infection coupled with reduced neutrophil 
influx likely contributed to the increase in lung virus titer in the fish oil fed mice. 
 The recruitment of T cells is dependent on cytokine-induced expression of 
adhesion molecules. For example, TNF-α and IL-1β stimulate endothelial cells to 
increase expression of adhesion molecules, selectins and intergrins (204, 205). As 
expected with an influenza virus infection, cytokine mRNA expression of TNF-α 
peaked at d 7 in control fed mice; however, with fish oil feeding this induction did not 
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occur, suggesting that a lack TNF-α may have contributed to the decrease in CD8+ T 
cell trafficking to the lung.   
The migration of CD4+ cells however, was not affected in fish oil fed influenza 
infected mice. Fish oil feeding may have altered pathways required for CD8+ T cell 
and not CD4+ T cell trafficking. For example, although both CD4+ and CD8+ T cells 
express CXCR3, administration of anti-CXCR3 antibody reduced CD4+ T cell 
infiltrate in the brain, while CD8+ trafficking was not affected (206). Similarly, CCR5 
is also expressed on both CD4+ and CD8+ T cells, although only CD4+ T cell 
trafficking was affected by lack of CCR5 expression in a mouse model of hepatitis 
virus (207). Interestingly, mRNA for MIP-1α, the ligand for CCR5, was 
underexpressed in the fish oil fed mice. While no studies have examined a direct 
effect of selective T cell recruitment with fish oil feeding during influenza infection, 
our results suggest that chemokines and perhaps their receptor expression may play 
a key role for the immunomodulatory effects of fish oil during influenza infection. 
TNF-α is produced by infected lung epithelial cells, activated macrophages, 
dendritic cells, neutrophils, T cells (CD8+ and CD4+) and NK cells (29, 122). During 
viral infection, TNF-α exerts antiviral activity (124), enhances the recruitment of 
leukocytes to the site of infection and it activates innate immune responses (208, 
209). IL-6 induction has pleiotropic effects, including the activation of NK cells and 
macrophages, and stimulation of T cell differentiation during influenza infection (129, 
208). The potential for n-3 PUFA to reduce pro-inflammatory cytokines has been 
shown previously (210). For example, studies of fish oil fed mice, that have been 
infected with lipopolysaccharide had decreased the ex vivo production of TNF-α, IL-
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1β and IL-6 by peritoneal macrophages and decreased TNF-α, IL-1β and IL-6 
concentrations in circulation (133, 134, 211).   
Together, these data suggest that the anti-inflammatory properties of fish oil 
that resulted in reduced neutrophils, NK cells and CD8+ T cells in the lung and 
decreased expression of mRNA for pro-inflammatory cytokines, likely led to the 
increased viral titer and subsequent higher mortality rate in the fish oil fed mice. 
Further mechanistic studies are needed to determine how PUFAs can influence the 
immune response to influenza infection. For example, studies have shown that lipid 
raft disruptions by n-3 PUFAs can affect signaling pathways in T lymphocytes and 
disrupt immunological synapse formation needed to activate T cells (47, 212). 
However, potential adverse effects of these alterations in vivo during an influenza 
virus infection have not been investigated.  
 In this study, we utilized both a physiologically relevant concentration of 
dietary fish oil supplementation and a natural route of administration of a viral 
pathogen. Results from our study suggest that fish oil consumption has the potential 
to increase the severity of an influenza virus infection and perhaps other viral 
illnesses as well. 
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Chapter III 
3 MODULATION OF THE INFLAMMATORY RESPONSE TO 
INFLUENZA VIRUS INFECTION BY N-3 POLYUNSATURATED 
FATTY ACIDS 
 
Nicole MJ Schwerbrock, Whitney Franz, Vivian Ariail, Erik A Karlsson, Patricia A 
Sheridan, Qing Shi, Melinda A Beck  
3.1 Abstract 
 
Anti-inflammatory properties of n-3 polyunsaturated fatty acids (PUFA), 
including eicosapentaenoic acid (24) and docosahexaenoic acid (DHA), are well 
known, however less is understood about their role during viral infection. We have 
previously reported that feeding mice a 4% menhaden fish oil diet increases 
morbidity and mortality following influenza virus infection. To further characterize the 
effects of n-3 PUFAs on the response to viral infection, we utilized both a mouse 
model of influenza infection as well as primary human bronchioalveolar cells.  We 
found that influenza virus infection induced a 6.3-fold increase in EPA content in the 
infected lung, whereas infection had little effect on DHA content. Although changes 
in fatty acid membrane composition can result in functional changes, the 
effectiveness of DCs from fish oil fed mice to stimulate T cells, or of pulmonary CD8+ 
T cells from fish oil fed mice to be activated by dendritic cells was not impaired. In 
response to viral infection, PUFA treated airway epithelial cells treated with DHA to 
EPA ratios of 25μM/25μM and 80μM/20μM significantly suppressed mRNA for type 
1 interferons, TLR-3, IRF-3/7 and RIG-1 in addition to mRNA levels for pro-
inflammatory cytokines IP-10 and IL-6. A DHA to EPA ratio of 20μM/80μM did not 
have this suppressive effect. Thus, n3-PUFA can substantially alter the response of 
primary epithelial cells towards a viral infection, with DHA being more effective than 
EPA. 
3.2 Introduction 
 
Polyunsaturated fatty acids (PUFA), particularly the n-3 PUFAs 
eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3), 
are abundant in fish oils, and exert anti-inflammatory functions in cell culture and in 
vivo (1, 134, 178, 213).  A number of studies have demonstrated the anti-
inflammatory properties of fish oils, including reduced natural killer function, reduced 
production of pro-inflammatory cytokines and decreased ability of macrophages and 
dendritic cells to present antigen to T cells (6, 143, 176, 177).   
Although the anti-inflammatory properties of PUFA have been shown to be 
beneficial for chronic inflammatory illnesses (12), these same anti-inflammatory 
properties can be detrimental for the response to acute infections when a pro-
inflammatory state is necessary for pathogen eradication (2, 214, 215). 
In our previous study, we demonstrated that feeding fish oil to mice increased 
their morbidity and mortality following infection with influenza virus (11). We found 
reduced NK and neutrophil infiltrate in the lungs of the infected fish oil fed mice, as 
well as a significant reduction in CD8+ T cells, which are required for influenza virus 
elimination. 
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Influenza viruses primarily target bronchial airway epithelial cells, in which 
they replicate and initiate innate immune responses to help limit the spread of the 
virus. Following infection, viral RNA is recognized by the pattern recognition toll like 
receptor (TLR)-3 and cytoplasmic retinoic acid-inducible gene (RIG)-1. Once 
activated, these host-virus interactions signal to trigger transcription factors needed 
to induce the production of type I interferon (IFNα/β) genes (216-218). Following 
infection, bronchial epithelial cells also produce various mediators that signal an 
inflammatory response including IL-6 (219), and interferon-induced protein-10 (IP-
10) (220).  
In addition to the innate response initiated by infection of the bronchoalveolar 
cells, the adaptive immune response begins within 7-10 days following infection. 
Dendritic cells take up and process viral antigen into peptide fragments which are 
presented on major histocompatibility I molecules to activate CD8+ T cells (149). 
PUFA treatment has been reported to interfere with the antigen presentation 
capability of dendritic cells (6). 
 In order to further understand how fish oils can modulate the immune 
response to influenza virus infection, we utilized both an animal model as well as an 
in vitro primary cell culture model to determine the effects of PUFA on infected 
epithelial cells as well as investigating the ability of dendritic cells from PUFA fed 
mice to present influenza antigen to T cells. 
3.3 Material and Methods 
 
Animals studies 
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Diet:  Six week old male C57BL/6J mice were obtained from Jackson Laboratories.  
All mice were housed at the University of North Carolina Animal Facility, which is 
fully accredited by the American Association for Accreditation of Laboratory Animal 
Care.  Animals were maintained under protocols approved by the Institutional Animal 
Use and Care Committee.  Mice were housed 4/cage with free access to food and 
water.  Mice were fed a control semipurified diet containing 5% corn oil (D0792502, 
Research diets INC) or a fish oil-corn oil diet at physiologically achievable levels (1% 
CO + 4% FO, D0792503, Research diets INC) for 2 weeks. 
Virus and infection:  The mouse adapted strain of influenza A/Puerto Rico/8/34 
(A/PR8) (American Type Culture Collection) was propagated in the allantoic fluid of 
10 day old fertilized chicken eggs, and the viral titer was determined by 
hemagglutination assay (221).  After 2 weeks on the diets, mice were anesthetized 
with an intraperitoneal injection of a ketamine (0.6 mg/kg)/xylazine (0.35 mg/kg) 
solution and infected intranasally with 0.05 mL of 2 hemagglutinating units (HAU) of 
A/PR8 virus diluted in PBS.  Previous studies from our laboratory determined that 
this dose of virus is sufficient to effectively elicit an immune response while causing 
little mortality in infected control mice (222).  
Extraction and measurement of fatty acids. Lipids were extracted from the lungs 
of non-infected and infected (day 7 post infection) mice using the method of Bligh 
and Dyer (223). An antioxidant (0.01%, w/v, BHT) was added to all solvents. 
Residual lipids were saponified (224). Resulting fatty acid methyl esters were 
analyzed using capillary gas chromatography (Perkin Elmer AutoSystem XL Gas 
Chromatograph, Shelton, CT). Heptadecanoic acid (17:0) was used as an internal 
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standard. Individual fatty acids were identified by comparing their retention against 
authentic standards (Nu Chek Prep, Elysian, MN). Data were analyzed with the 
Perkin Elmer Totalchrom Chromatography Software, version 6.2. The obtained 
results were provided as % FA of total tissue sample.  
Antigen presentation assay.  Dendritic cells (DC) were isolated from spleens of 
control diet and fish oil diet uninfected mice (n=10 per group) and processed into 
single-cell suspensions by mechanical agitation as described previously (225). Cells 
were counted and 1 × 108 cells were used to isolate DCs using the DC enrichment 
kit from Dynal Biotech (Carlsbad, CA). This population was shown to be greater than 
92% pure by FACS analysis. T cells were isolated from spleens of control diet fed 
mice (n=8) that had been infected with influenza 7 days previously. Cells were 
counted and 1 × 108 cells were used to isolate T cells using the T cell enrichment kit 
from Dynal Biotech (Carlsbad, CA). DCs were incubated at a multiplicity of infection 
(MOI) of 2 with 56°C heat-inactivated influenza A/PR8 for 2 hr followed by extensive 
washing to remove any excess virus.  
DCs were incubated with T cells in an 1:2 ratio with 1 × 105 DC in a 96-well round-
bottom microplate. Samples were incubated for 2 hr at 37°, followed by the addition 
of Golgi Plug (BD Biosciences) and incubation for an additional 4 hr. Prior to surface 
staining, Fc receptors were blocked with anti-FcγII/III. Cells were stained with DC 
marker: FITC-anti-CD11b, PE-anti-MHCII, APC-anti-CD11c, PeCy5- anti- CD86 or 
FITC-anti-CD80, PE-anti-11b, APC-anti-CD11c, PeCy7- anti- CD45R. 
T cell function.  DC from control fed mice were processed as described above. T 
cells from fish oil fed mice infected with influenza 7 days earlier were isolated as 
  65
described and cultured with DC at a DC/T cell ratio of 1:5. After 2 hours of 
incubation, cultures were processed as described above and stained with: FITC-anti-
CD3, PE-anti-INF-γ, APC-anti-CD4, PeCP - anti- CY5.5 Cy5, PE- anti-gramzyme B 
(BD Biosciences), followed by fixation and permeabilization for subsequent 
intracellular staining with PE-anti-IFN-γ. An irrelevant PE-IgG (Sigma) was used as a 
staining control.  
Preparation of PUFA media for cell culture: DHA and EPA were supplied in 
ethanol solution (Cayman Chemical) and dried under N2 gas to minimize oxidation. 
All fatty acids were prepared as 50mM stock solutions in 35% BSA and incubated for 
1 h at at 37°C. Stock BSA-fatty acid complexes were added to growth media at final 
DHA to EPA growth media concentrations of 25μM/25μM; 20μM/80μM and 80μM 
/20μM. Media were prepared freshly for each experiment.  
Primary human bronchial epithelial cells were obtained from healthy nonsmoking 
adult volunteers by cytologic brushing at bronchoscopy and plated as described 
previously (226). Upon confluence, PUFA were added to the bronchial epithelial 
growth media (Cambrex Bioscience Walkersville, Inc. Walkersville, MD) under air 
liquid interface (ALI) culture conditions (removal of the apical medium).  
Cell culture infection with influenza. Influenza A/Bangkok/1/79 (H3N2 serotype) 
was propagated in 10-day-old embryonated hen’s eggs. The virus was collected in 
the allantoic fluid and titered by 50% tissue culture infectious dose in Madin-Darby 
canine kidney cells and hemagglutination as described before (227). For infection of 
differentiated bronchial epithelial cells (ALI) approximately 3 × 105 cells were 
incubated with 320 HAU of influenza A Bangkok 1/79 on the apical side for 1 h, after 
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which the remaining unattached virus was removed. This infection protocol results in 
a mild infection in which about 10–20% of the cells become infected with influenza. 
Following infection, apical cell surface was washed with DMEM/2% fetal calf serum 
and control or PUFA bronchial epithelial growth media was added. Samples were 
harvested at 8 hours and stored at - 70 °C for further analysis.  
Determination of mRNA levels. At 8 hours post infection, total RNA was isolated 
from the ALI cells using TRIzol and reverse transcription reaction was carried out 
with the RNeasy Mini Kit (Qiagen).  Using quantitative real time polymerase chain 
reaction (RT-PCR), mRNA levels were measured for human β-actin, interferon-
inducible protein 10 (IP-10), interleukin 6 (IL-6), interferon regulatory factor (IRF)-3 
and IRF-7, toll like receptor-3 (TLR-3), and retinoic acid-inducible gene I (RIG-I).  All 
measured gene expression was normalized with respect to the reference gene of β-
actin, which is ubiquitously expressed in eukaryotic non-muscle cells. Resulting data 
were expressed as percent reduction compared with infected non-PUFA treated 
cells. 
Statistical analysis.  Statistical analyses were performed using JMP Statistical 
Software (SAS Insititute).  Student's t test was used for post-hoc comparison 
between the dietary groups. Nonparametric data were analyzed using Kruskal Wallis 
test. 
3.4 Results 
 
Infection of fish oil fed mice with influenza virus alters lung fatty acid 
composition.  The lung is the site of infection for influenza virus. We tested whether 
infection itself could alter the fatty acid profile of lung cells. As shown in figure 1, as 
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expected, fish oil feeding alone increased both DHA and EPA percentages in lung 
tissue of uninfected mice. Interestingly, infection with influenza could also modify 
PUFA incorporation into lipid membranes. As shown in Figure 3.1A, infection with 
influenza caused a 6.3-fold increase in EPA concentration. DHA concentrations did 
not change with infection (Fig 3.1B). In control fed mice, EPA and DHA levels did not 
change with infection.  Arachidonic acid (AA) concentration increased 42 % with 
infection in the PUFA fed mice, although this percentage was still below the level 
seen in control fed.  
 
 
Figure 3.1 Effects of influenza infection and fish oil feeding on percent fatty acids in the lung.  
Lipids were extracted using the method of Bligh and Dyer (223) and resulting fatty acid methyl esters 
were analyzed using capillary gas chromatography. Percent total (A) EPA levels, (B) DHA and (C) 
AA. Values are expressed as means ± SD, n = 4-6 per group per time-point. *P < 0.05. 
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Fish oil feeding does not alter antigen presentation.  Previous studies 
have demonstrated that fish oil feeding can alter the ability of dendritic cells to 
function properly (45, 228). To examine this possibility in our influenza-infected fish 
oil fed mice, we tested the ability of dendritic cells from PUFA fed mice to activate 
CD8+ and CD4+ T cells to produce IFN-γ. We found that influenza-pulsed DCs from 
spleens of control and fish oil fed mice effectively induced CD8+ (Fig 3. 2A) and 
CD4+ (Fig 3. 2B) T cells from control fed mice to produce IFN-γ.  In addition, we 
tested the ability of dendritic cells from control fed mice to activate CD8+ T cells from 
PUFA fed and control fed mice. Similar to our results above, we found no differences 
in the ability of CD8+ T cells from PUFA fed mice compared to control mice to 
produce IFN-γ following dendritic cell stimulation (data not shown).  
 
 
 
 
Figure 3.2 Fish oil feeding does not alter the ability of dendritic cells from PUFA fed mice to activate 
(A) CD8+ and (B) CD4+ T cells.  
An antigen presentation assay was performed using T cells isolated from spleens of influenza-
infected control diet fed mice at day 7 p.i. The T cells were incubated with influenza-pulsed DCs 
isolated from spleens of uninfected control and fish oil fed mice for 4hr. The percentage of interferon 
(IFN)-γ+CD8+ and (IFN)-γ+CD4+ T cells in the CD3+ lymphocyte population was determined by 
intracellular cytokine staining and flow cytometry. Data are expressed as the mean ±SEM and are 
representative of two separate experiments (n= 8 pooled mice per group per experiment). Values 
presented have been corrected for the per cent non-specific immunoglobulin G (IgG) staining 
*P ≤ 0·05. 
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n-3 PUFA treatment of human bronchioalveolar cells decreases antiviral 
responses to influenza virus. To test the ability of PUFA treatment to modulate 
bronchial epithelial cell response to influenza infection, we treated primary 
bronchoalveolar air liquid interphase (ALI) cells with 3 different ratios of DHA to EPA: 
25μM/25μM; 20μM/80μM and 80μM /20μM. As shown in Figure 3. 3, mRNA levels 
for TLR3 (Fig 3. 3A), RIG1(Fig 3. 3B), IRF-3(Fig 3. 3C), IRF-7 (Fig 3. 3D), IP-10 (Fig 
3. 3E),  and IL-6 (Fig 3. 3F),  8 hours post infection were all significantly reduced in 
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the 25μM/25μM and 80μM /20μM ratios compared with infected cells not treated with 
PUFAs. Interestingly, the 20μM/80μM ratio had no effect on the mRNA levels.  
 
 
 
Figure 3.3 Influenza infected human bronchoalveolar cells exposed to varying concentrations of DHA 
and EPA have altered mRNA expression.   
Cells were treated for 48 hours prior to influenza virus infection. mRNA levels were determined 8 
hours post infection for  (A) TLR-3,  (B) RIG-1 (C)  IRF-7,  (D) IRF-3 (E)  IP-10 (F) IL-6 are shown.  
Uninfected n-3 PUFA treated cells and non PUFA treated control cells did not express mRNA levels 
for any antiviral and pro-inflammatory cytokine measured. Values are means + SD, n = 2.  
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3.5 Discussion 
 
The anti-inflammatory properties of n-3 PUFA have been described in many 
systems (174, 228). However, during infection, reduced inflammation could actually 
harm the host. Indeed, our previous study demonstrated that fish oil feeding 
increased morbidity and mortality of influenza-infected mice (214). To further 
characterize the effect of PUFA on the response to viral infection, we utilized both a 
mouse model of influenza infection as well as primary human bronchoalveolar cells.   
Fish oil feeding has been shown previously to modify lipid membrane 
composition (46, 229, 230). However, it is not known if infection can modify 
membrane content of EPA and DHA. For the first time, we demonstrated that 
influenza virus infection can alter the lipid membrane profile of bronchoalveolar cells, 
inducing a significant increase in EPA and AA content in the infected lung. However, 
infection had little effect on DHA content. Interestingly, the DHA and EPA content of 
control fed mice were not altered during infection.  
DHA is the most abundant n-3 PUFA in most tissues and its turnover is 
relatively low (231, 232). EPA exerts its anti-inflammatory function by serving as a 
competitive precursor for eicosanoids synthesis (13, 62). It is therefore possible that 
the increase in EPA during infection is a response of the cells need to control the 
inflammatory response induced by a viral infection (13, 62). The increase in AA 
levels, on the other hand, may reflect induction of pro-inflammatory prostaglandin 
synthesis which is needed to induce the inflammatory responses (233). However, 
the increased level of EPA in the infected fish oil fed mice led to an over-reduction in 
inflammation compared with control fed mice, resulting in less inflammation along 
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with increased viral titers (11). In contrast, control diet fed mice showed no alteration 
in the n-3 fatty acid profile, suggesting that increased incorporation of EPA into cell 
membranes during infection only occurs when n-3 PUFA is in excess. 
During infection with influenza, DCs provide a critical role in activating T cells 
necessary for fighting the infection. Given that n-3 PUFAs have been reported to 
inhibit the antigen-presentation function of KLH–sensitized rat splenocytes and 
dendritic cells (45, 53, 228) in addition to decreased IFN-γ production during viral 
infection (37), we were surprised to find no functional changes in regard to 
effectiveness of DCs from fish oil fed mice to stimulate T cells, or of pulmonary CD8+ 
T cells from fish oil fed mice to be activated by dendritic cells from control fed mice. 
There are several explanations for our findings. DHA is considered to be more 
effective at altering cell membrane functions such as membrane fluidity and 
immunological synapse formation (234, 235). Because DHA levels were not altered 
during infection, perhaps a threshold amount was not reached to induce these 
changes. Many studies that used fish oil diets had a much higher amount of fish oil 
compared to our study diet (109, 120, 236, 237). In our study, we utilized a 4% 
menhaden fish oil diet that corresponds to a blood level of ~68μM DHA and ~ 28μM 
EPA. Previous studies that have demonstrated effects of fish oil on antigen 
presentation and/or T cell function used much higher levels of fish oil from 25-35% 
(26,27,33) Studies that used 20% or more fish oil feeding demonstrated decreased 
cytotoxicity of peritoneal exudate cells against P51 tumor cells (238) and decreased 
proliferation of Con A-stimulated spleen lymphocytes (236).  In addition, our study 
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analyzed an antigen-driven response, rather than a mitogen response, which is 
more common in fish oil studies (109, 120, 236, 237).  
Airway epithelial cells are the primary targets for influenza virus (180). In 
response to RNA virus infection, bronchoalveolar cells activate TLR-3 and RIG-1 
(239) signaling, which ultimately results in the production of pro-inflammatory 
cytokines and type I interferons (16, 42). Additional activation of interferon regulatory 
factors by viral infection also enhances the transcription of type I IFN genes resulting 
in an amplified anti-viral response (240, 241). We found that specific n-3 PUFA 
ratios had a suppressive effect on mRNA expression for TLR-3, IRF-3 and 7 and 
RIG-1.  PUFA treatment of ALI cells at DHA to EPA ratios of 25μM/25μM and 
80μM/20μM significantly suppressed TLR-3, IRF-3 and 7 and RIG-1 mRNA levels. In 
addition, mRNAs for two pro-inflammatory cytokines, IP-10 and IL-6 were also 
suppressed by these PUFAs ratios. These data suggest that PUFA treatment 
suppressed the induction of antiviral and pro-inflammatory cytokines following 
influenza infection. This is the first study that demonstrates physiologically relevant 
levels of EPA and DHA can inhibit the influenza anti-viral response of primary 
bronchial epithelial cells. 
Related studies have investigated the effects of individual n-3 fatty acids on 
the production of pro-inflammatory cytokine synthesis. For example Saedisomeolia 
et al. (242) reported that DHA at high concentrations (400μM) resulted in a 
significant reduction in pro-inflammatory cytokines in rhinovirus infected Calu-3 
airway epithelial cells, whereas EPA at high (400μM) and DHA at lower 
concentrations (10-200μM) had no effect on cytokine production (242). Similarly, 
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Bryan et al. (233) reported  that supplementation of A549 cells with DHA at 50μg/ml 
(~200μM) resulted in a significant reduction of the chemokine regulated upon 
activation normal T cell expressed and secreted (RANTES) following histamine 
stimulation, whereas concentrations of EPA (high and low) and DHA of 10μg/ml 
(~40μM) did not elicit any suppression of RANTES or other pro-inflammatory 
cytokines measured. These studies all used high levels of EPA and DHA in 
transformed cell lines. It may be that much lower levels of DHA and EPA are 
effective in primary cell cultures.   
DHA has been suggested to significantly alter basic properties of cell 
membranes, including acyl chain order and fluidity, phase behavior, fusion, rapid flip-
flop of proteins in the cell membrane and resident protein function (7, 243). It is 
therefore plausible that DHA related lipid membrane modulations may have 
disrupted antiviral and pro-inflammatory cytokine signaling pathways. Lee et al. 
(244) used an LPS-stimulated macrophage culture model to show that TLR-4 and its 
inflammatory downstream cascade are affected by DHA, although membrane 
integrity was not determined. Thus, it is possible that DHA specifically modulated 
membrane receptor associated signaling events whereas EPA compromises anti-
inflammatory effects by different mechanisms.  
In our previous study, we found that fish oil feeding decreases immune cell 
trafficking in the lungs of infected fish oil fed mice (214). In this study we 
demonstrated that although dendritic and CD8+ T cell function was not affected by 
fish oil feeding, PUFA treatment inhibited influenza anti-viral responses of primary 
bronchial epithelial cells. Taken together, our data suggest that the fish oil related 
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decrease in inflammatory cell recruitment to the lungs of influenza infected mice (11) 
may have been a result of suppressed antiviral and pro-inflammatory cytokine 
induction in the bronchial epithelial cells following infection.  
Further mechanistic studies are needed to determine how DHA and EPA 
could have differential effects on the immune response to infectious disease. For 
example, EPA has been shown to control the activity of transcription factors PPAR 
α/γ and nuclear factor-κB, (NF-κB), and depending on its concentration can induce 
anti-inflammatory effects (1, 245-247). 
Because of the reported health benefits of fish oil, fish oil supplementation 
has increased in this country (27, 181).  Given that fish oil supplementations have 
differing ratios of DHA and EPA (248), and that DHA and EPA have differing effects 
on different cell populations, there may be public health implications of fish oil 
supplementation during an infection. Further mechanistic investigations in n-3 PUFA 
effects on the response to viral disease is warranted.  
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 Chapter IV 
4 DIETARY FISH OILS MODULATE IMMUNITY TO 
INFLUENZA VIRUS INFECTION: A SYNTHESIS 
 
The immunosuppressive properties of dietary omega -3 polyunsaturated fatty 
acids (PUFA) have been demonstrated to be beneficial in chronic inflammatory and 
autoimmune disorders (4, 5). However, in our studies we showed that these same 
anti-inflammatory properties can be detrimental by reducing the immune response to 
a viral infection when a fully intact immune system is essential for eradicating an 
invading pathogen. Intakes of omega -3, therefore, contribute to both beneficial and 
adverse host outcomes. 
 
Infection with influenza virus is very common. On average, in any given year 
5% to 20% of the population in the United States becomes infected, and during a 
pandemic, 20-40% of the world’s population might be infected (34). Despite the 
availability of vaccines and antiviral agents, influenza virus continues to be a major 
cause of morbidity and mortality worldwide.  Following infection, immune regulation 
is necessary for both clearance of the virus and host protection.  
 
Given that fish oils have the ability to suppress immune functions; dietary fish 
oils have been hypothesized to reduce host resistance against influenza virus 
infection. The concept that suppression of inflammation can be associated with 
increased severity of infectious diseases was initiated by epidemiologists (249). 
These investigators reported a lower incidence of autoimmune diseases in 
Greenland Eskimos, a population that traditionally consumes a diet rich in omega-3 
PUFA from fish oils. However, these same populations presented grater incidence of 
infectious diseases, such as tuberculosis and recurring respiratory tract infections, 
than in populations on much lower intakes of fish (249). 
 
Chapter 2 of this dissertation demonstrated that in the case of influenza virus 
infection in mice, the anti-inflammatory properties of fish oil were associated with a 
poor outcome post-infection. Results presented in Chapter 3 demonstrated that 
although dendritic and CD8+ T cell function was not affected by fish oil feeding, 
PUFA treatment inhibited influenza anti-viral responses of primary bronchial 
epithelial cells. Taken together, our data suggests that the fish oil related decrease 
in inflammatory cell recruitment to the lungs of influenza infected mice (Chapter 2) 
may have been a result of suppressed antiviral and pro-inflammatory cytokine 
induction in the bronchial epithelial cells following infection.  
 
These results presented in those two chapters need to be considered in 
greater depth as to the mechanisms by which dietary fish oils can potentially 
increase susceptibility to viral infection, in general. Better understanding of how 
PUFAs modulate host resistance to infectious agents will allow us to devise better 
dietary strategies using omega-3 fatty acids for both the prevention and treatment of 
illnesses. Additional experimental designs using other animal models and human 
subjects are also needed to corroborate and support our current findings. 
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Specific topics investigated in our studies are covered next. 
4.1  Impaired resistance to influenza infection in fish oil fed mice: Summary 
of results from chapter 2  
 
Following influenza infection the immune system protects the host with 
coordinated responses against the virus. Disruption of such reactions may be 
detrimental. In our studies, we tested the hypothesis of whether the 
immunosuppressive properties of fish oil feeding could hinder immunity to influenza 
and found that fish oil feeding led to increased mortality in mice infected with 
influenza virus.  
 
Despite a significant reduction of lung inflammation, fish oil fed mice had a 4-
fold increase in mortality and surviving mice had prolonged recovery period following 
infection. The rapid recruitment of inflammatory cells to the site of infection is 
essential to eliminate the invading virus but these cells also contribute to additional 
tissue pathology. Since lung inflammation was greatly reduced, this decrease 
suggested that immune cell trafficking into the lung were absent in fish oil fed mice. 
 
 We initiated our studies by analyzing cells of innate immunity, i.e. NK and 
neutrophils and others. These present the first line of defense to viral infection, but 
they also stimulate the recruitment and activation of cell-mediated immunity that 
helps limit viral spread. We found that fish oil feeding resulted in lower numbers of 
neutrophils and NK cells in infected lungs, indicating that the recruitment and 
trafficking of these cells may not adequately occur in fish oil fed mice. Functionally, 
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NK cells retained their cytotoxicity in infected lungs, whereas in the spleen NK 
cytotoxicity was decreased, suggesting that fish oil feeding affects NK mediated 
target cell lysis differently depending on the type of infection and the resulting 
cytokine milieu present. Furthermore, cytotoxic CD8+ T cells numbers were 
decreased with fish oil feeding in infected lungs, while CD4+ T cells numbers did not 
change, indicating that fish oil feeding may have altered pathways required for CD8+ 
T cell but not CD4+ T cell trafficking. Thus, the increase in lung virus titer in the fish 
oil fed mice likely was attributed to the reduction in CD8+ T cell number post-
infection coupled with a reduction in the influx of immune cells during the early stage 
of infection.  
 
 In this study we also found that the induction of TNF-α, MIP-1α, and IL-6 
mRNA was suppressed with fish oil feeding. Since these cytokines are primarily 
involved the expression of adhesion molecules, neutrophil trafficking (196), and 
activation of immune cells (208) the down-regulation indicates that the impaired 
recruitment of inflammatory cells to the site of infection may have been dependent 
on the cytokine response in infected lungs (Chapter 2).  
 
These data demonstrate, for the first time, that fish oil feeding, at 
physiologically relevant levels, resulted in increased mortality in flu-infected mice. 
We showed that fish oil feeding restrained immune cell trafficking in conjunction with 
higher virus titer in influenza virus infected lungs. Thus, at least in the case of 
influenza virus infection, the immunosuppressive properties of dietary fish oils were 
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associated with poor outcomes post-infection, both increased death and slow 
recovery among survivors. 
 
Molecular mechanisms by which omega-3 fatty acids modulate immune 
function include inhibition of the production of cytokines, membrane modulation, 
alternation of antigen presentation and enhancing eicosanoid production. Studies in 
chapter 2 focused on how the anti-inflammatory properties of fish oils can affect 
responses to viral infection. Specifically, focus was placed on changes in the innate 
immune components and their attempt to eliminate the invading virus.  In chapter 3 
we selectively determined if n3-PUFA treatment affects immune responses of 
primary epithelial cells towards viral infection.  
 
4.2 Impaired virus release in omega-3 treated primary cultured human 
bronchial epithelial cells: Summary of results from chapter 3 
 
In the previous study we found that fish oil feeding led to reduced CD8+ T cells 
in lungs of infected mice. Since CD8+ T cells play a critical role in actively killing 
virally infected cells, we analyzed their functional capacity. As reported in chapter 3, 
we found that CD8+ T cells obtained from infected lungs of both diet groups were 
equally effective in responding to antigens presented to them.  
 
Moreover, spleen dendritic cells play an important role in activating T 
lymphocytes (250). Because diminished antigen presentation of dendritic cells had 
been reported in rats fed high fish oil diets (45), we examined dendritic cell functional 
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capacity and the subsequent T cell response in ex vivo splenocytes (Chapter 3). We 
found that splenic CD4+ T cells from fish oil fed mice responded less strong to 
antigen presentation than control cells, although the difference from control fed mice 
was not significant. It is, therefore, possible that the newly discovered modulations of 
antigen presentation by n-3 PUFA treated T cells are dependent on differing diet 
treatment or experimental model used. 
 
Additionally, fish oil feeding had been shown previously to modify lipid 
membrane composition. However, it was not known if infection can modify 
membrane content of EPA and DHA. For the first time, we demonstrated in chapter 
3 that influenza virus infection can alter the lipid membrane profile of 
bronchoalveolar cells, inducing a significant increase in EPA and AA content in the 
infected lung. However, infection had little effect on DHA content. Interestingly, the 
DHA and EPA content of control fed mice were not altered during infection. These 
data suggested that diverse PUFAs are differently affected with infection. 
 
Thus, we now had shown in vivo that dietary fish oils altered membrane lipid 
composition and decreased inflammatory cell trafficking and this decrease in 
recruitment was most likely due to a suppressed pro-inflammatory cytokine 
induction. Because the lung airway cells are the primary targets for influenza 
infection, we next determine if n-3 PUFA treatment can alter immune responses to 
influenza virus infection, in vitro. 
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In response to viral RNA infection, bronchoalveolar cells activate various 
signaling pathways which ultimately results in the production of pro-inflammatory 
cytokines and type I interferons. Additional activation of interferon regulatory factors 
by viral infection also enhances the transcription of type I IFN genes resulting in an 
amplified anti-viral response. We found that specifically DHA to EPA ratios of 
25μM/25μM and 80μM/20μM suppressed the expression of pro-inflammatory 
signaling pathway intermediates. However, this was not the case in DHA to EPA 
ratios of 25μM/25μM. Our data suggested both to us, PUFA treatment, at 
physiologically relevant levels, suppressed the induction of antiviral and pro-
inflammatory cytokines and that that DHA and EPA had differential effects on the 
immune response to influenza virus infection.  
 
This dissertation studies demonstrate that n-3 PUFAs administered at 
physiological levels, significantly altered host immunity to influenza virus.  
For the first time we have shown that influenza infection in fish oil fed mice lead to 
increase mortality and altered n-3PUFA membrane profiles. Thus, at least in the 
case of influenza virus infection, the immunosuppressive properties of dietary fish 
oils were associated with poor outcomes post-infection, both increased death and 
slow recovery among survivors.  
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4.3 Assessing alternate possibilities for decreased survival of influenza 
infection in fish oil fed mice. 
 
 Epithelial cells of the lung are central to respiratory gas exchange. Loss of 
functionality can lead to death. Since the ability of n-3 PUFAs to arrest cell growth 
and induce apoptosis has been reported previously (3, 251, 252), we determined if 
an increase in apoptotic lung cells could be accountable for the 4-fold increase in 
mortality illustrated in chapter 3. Using TUNEL staining to identify apoptotic cells, we 
found a direct correlation between levels of inflammation and apoptosis. Thus, fish 
oil fed mice had fewer apoptotic cells (and reduced inflammation) compared with 
control mice which had more apoptotic cells (and increased inflammation). Thus, the 
fish oil fed mice did not die from in increase in lung cell death.  
 We next evaluated if the cause of higher mortality in fish oil fed mice, may 
have been due to the virus infecting the brain and the resulting encephalopathies led 
to death (253, 254). Of the three regions examined for the presence of virus (by 
measuring influenza matrix RNA) olfactory bulb, hypothalamus and brain stem, we 
found virus predominately in the olfactory bulb, however, there were no significant 
differences between both diet groups in regard to viral RNA expression (data not 
shown). These data indicated that virus spread into the brain was not a cause for the 
decrease survival seen with fish oil feeding.  
 
 Lastly, we examined mouse liver and kidney function, since PUFAs have 
been linked to affect these organs in influenza associated Reye’s syndrome (255, 
256). We found that following influenza infection, alkaline phosphatase (liver 
function) was not affected by fish oil feeding (data not shown).  Blood urea nitrogen 
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(kidney function test) levels on the other hand were decreased; indication that the 
general cacaxiatic state of fish oil feeding may have lead to dehydration of infected 
mice. 
4.4 Potential further directions of investigation of n-3 PUFAs in immunity 
  Our study sets the stage for further investigations of how anti-inflammatory 
properties of nutrients can affect host immune function. Further mechanistic studies 
are needed to determine how PUFAs can influence the immune response to 
influenza infection.  
4.5 Future directions 
4.5.1 Immune cell trafficking  
 The migration of immune cells to the site of infection is dependent on the 
production of cytokines that stimulate endothelial cells to rapidly express adhesion 
molecules. Circulating phagocytic cells express surface receptors that bind to 
adhesion molecules. Given that fact that n-3 PUFAs decrease production of 
inflammatory cytokines and decrease adhesion molecule expression, suggests that 
the effects we see on decreased immune cell trafficking into the infected lungs may 
be mediated through PUFAs potential in down regulating adhesion molecule 
expression. The studies in chapter 2 clearly illustrate that alteration in immune cell 
recruitment may have been in part regulated by the cytokine/chemokine gradient. 
Therefore determining, the mediators of cell trafficking would provide a mechanism 
by which fish oil feeding leads to immune cell trafficking dysregulation. 
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4.5.2 Eicosanoid production and lymphocyte proliferation. 
 Although our findings in chapter 3 showed that antigen presentation was not 
affected by fish oil feeding, we found CD8+ T-cells to be decreased with fish oil 
feeding. Studies have suggested that the link between fatty acid and lymphocyte 
function is the production of eicosanoids (60).  Since n-3 fatty acids antagonize the 
production of inflammatory eicosanoid mediators from arachidonic acid, there is 
reason to hypothesize that during influenza infection, the production of 
prostaglandins from PUFAs is essential.  For example, studies have demonstrated 
that the deficiency of COX-1 and COX-2 leads to contrasting effects in the host 
response to influenza infection, and these differences are associated with altered 
production of prostaglandins and leukotrienes following infection. COX-1 deficiency 
is detrimental whereas COX-2 deficiency is beneficial to the host during influenza 
viral infection (257). Thus, determining how fish oil feeding affects prostaglandin 
production in response to influenza infection, may determine if impaired resistance 
to influenza infection in fish oil fed mice is eicosanoid mediated. 
4.5.3 Assessing viral and host factors involved in viral morphogenesis and 
budding. 
 In chapter 3 we demonstrated in cell culture experiments that DHA and EPA 
treatment resulted in dysregulated immune responses to influenza virus. For 
influenza virus to bud efficiently, viral hemagglutinin (HA) glycoprotein has to 
concentrate at membrane lipid aggregates (87, 102).  Because PUFA affects 
membrane compositions it is hypothesized that viral release from the infected cell 
may be impaired. Thus it will be important to determine if n3-PUFA treatment can 
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alter viral morphogenesis and budding. Optical imaging technique (confocal 
microscopy) can be used to visualize host membrane associated viral M1 protein 
(258). Demonstrating visually the effects of n-3 PUFAs on viral replication and 
release will further enhance our understanding at what stage omega-3 treatment can 
affect immunity. 
4.6 Conclusions 
 Previous studies in our laboratory have demonstrated that the host nutritional 
status can impair immune responses to viral infection (183). This was shown in 
animal models for obesity (184) and deficiencies of vitamin E (259) , selenium (185) 
and vitamin C (260). The present study additionally provides evidence that n-3 
PUFAs have to be considered when faced with infection.  Given that fish oil 
supplementations have differing ratios of DHA and EPA and that DHA and EPA 
have differing effects on different cell populations, there may be public health 
implications of fish oil supplementation during an infection.  
 In conclusion, do we supplement with n-3 PUFAs or not ?  - A two horned 
dilemma –  
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